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In the present study, three types of oncogene transgenic zebrafish lines were 
characterized: two inducible expression lines with oncogene mouse c-myc (mMyc)—
Tg(lfabp:Tre/rtTA-mMyc-GFP) and Tg(mvtg1:mMyc-GFP), and one direct expression 
line with oncogene Xmrk—Tg (lfabp:Xmrk). 
 
Tg(lfabp:Tre/rtTA-mMyc-GFP) lines utilized Tet-on inducible system, so the 
expression of the transgene can be activated with Dox treatment. To investigate the 
potential to develop tumors, the fish were treated with Dox (30 ug/ml &60 ug/ml) 
from 21 dpf. Around 20 days post-treatment, all the treated fish developed an enlarged 
belly. Fish from 60 ug/ml group had a severer phenotype than 30 ug/ml group, and 
were later diagnosed as hepatocellular hyperplasia and hepatocellular adenoma by 
histopathology analysis.  
 
Tg(mvtg1:mMyc-GFP) line utilized the Medaka vitellogenin 1 (mvtg1) gene promoter, 
and we found that this mvtg1 gene promoter was also E2-inducible in transgenic 
zebrafish, as in Medaka. By measuring the absolute concentrations of zvtg1 and mMyc 
RNAs, we found that the efficiency of the mvtg1 gene promoter is quite low, which 
probably explained why Tg(mvtg1:mMyc-GFP) line failed to develop abnormal 





Tg (lfabp:Xmrk) lines are direct expression lines, which means that oncogene Xmrk is 
constitutively expressed in the fish liver. However, no obvious abnormality was 
observed from F1 to F4 generations up to 1.5 years of age, while the survival rate at 
the early stages is also normal in compared with wild type fish. The study to cross Tg 
(lfabp:Xmrk) lines with p53
214K
 mutant line is still in process, and from the 
preliminary results of this study we found that the survival rate of the Xmrk (+/-) 
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1.1 Zebrafish as an excellent model for vertebrate developmental studies 
 
The zebrafish (Danio rerio) is a small tropical freshwater species originated from 
northern India. As early as the 1970s, George Streisinger and colleagues described the 
use of zebrafish as a model organism for studying embryogenesis (Detrich et al. 1999; 
Streisinger et al. 1981), and it has become a popular and useful model organism for 
studying vertebrate development and gene function. They may supplement higher 
vertebrate models, such as rats and mice. However, as an experimental animal model 
in this area, the zebrafish has many innate advantages. Firstly, when zebrafish mate, 
they produce large numbers (100–200) of external, transparent embryos. Secondly, in 
these embryos, cleavage divisions, gastrulation, morphogenesis and organogenesis 
occur within 24 hours. Although the overall generation time of zebrafish is 
comparable to that of mice, zebrafish embryos develop rapidly, progressing from eggs 
to larvae in less than three days. Thirdly, the embryos are large, robust, and 
transparent and develop externally to the mother, which all facilitate experimental 
manipulation and observation (Dahm et al. 2006).  
 
1.2    Zebrafish as an emerging cancer model 
1.2.1 The neoplasm of zebrafish 
 
Fish has been used to study cancer for almost a century. Since Gaylord started the 




studies on Xiphophorus have showed that melanomas develop when Xiphophorus 
helleri (sword tails) are mated with a hybrid fish that is created via artificial 
insemination from two different species, Xiphophorus helleri and Xiphophorus 
maculates (Gordon et al., 1931; Walter et al., 2001). Over the years, many fish other 
than trout and Xiphophorus have been used in experimental carcinogenesis studies, 
including medaka, top minnow, sheepshead minnow, western mosquitofish, guppy 
and zebrafish (Law et al., 2001).  
 
The zebrafish was the first fish species used as a chemical carcinogenesis model. In 
the 1960s, Stanton et al. (1965) exposed zebrafish to diethylnitrosamine, and found 
that they developed hepatic neoplasms. During the following years, researchers 
started to use similar approaches in other fish species and the medaka became one of 
the best-characterized small fish for carcinogenesis studies (Bunton et al., 1990; 
Bunton et al., 1996).
 
In the 1980s and 1990s, the rise of zebrafish genetics gave 
zebrafish the momentum as a model of chemical carcinogenesis (Hendricks et al., 
1996; Tsai et al., 1996).
  
 
A common observation, regardless of the species, is that fish have a very low 
incidence of spontaneous cancers, but a high rate of tumorigenesis after carcinogen 
treatment. In most cases, the neoplasms of fish are quite relevant to human cancer 
biology. At the level of histopathology, fish neoplasms are strikingly similar to human 




developed spontaneously in the offspring of an ENU (ethylnitrosourea)-mutagenized 
line. Histologically, the zebrafish tumour shows the same nuclear-atypia, haphazard 
gland arrangement, desmoplastic stromal response and locally invasive behavior as 
human pancreatic adenocarcinomas. Wide range of carcinomas, sarcomas and other 
tumours are also observed in zebrafish. 
 
1.2.2 Cancer genes in zebrafish 
 
To date, little is known about fish neoplasia at molecular level. However, some 
evidence indicates that certain key players in human cancers are involved in fish 
tumorigenesis. For instance, p53 is a transcription factor which in humans is encoded 
by the TP53 gene and it regulates the cell cycle and thus functions as a tumor 
suppressor that is involved in preventing cancer. It coordinates the cell’s response to 
genotoxic stress in mammalian systems, and is regulated by the inhibitor Mdm2, 
which ubiquitylates p53, leading to its degradation. The regulation of apoptosis by 
p53 has been examined in zebrafish embryos
 
by using antisense morpholino 
oligonucleotides to ―knockdown‖ or reduces the p53 expression in zebrafish embryos 
(Langheinrich et al., 2002). When these embryos with low levels of p53 expression 
were exposed to DNA-damaging stimuli, such as ultraviolet irradiation, ionizing 
irradiation or the chemotherapeutic drug camptothecin, they had a reduced apoptotic 
response compared with control embryos, indicating that in zebrafish p53 activates 




when anti-mdm2 morpholinos were injected into embryos, they underwent high levels 
of apoptosis. However, this phenotype could be rescued by co-injection with anti-tp53 
morpholinos, indicating that the apoptotic phenotype in the absence of Mdm2 is 
mediated by p53. This result is, again, in agreement with the known regulation of p53 
by Mdm2 in mammalian systems. 
 
Cancer genes in zebrafish can also be studied by looking for orthologues of common 
human oncogenes and tumour-suppressor genes in zebrafish genome. Many 
orthologues have been found for most cancer genes, although few have been cloned 











A                                 B 
 
Figure 1. Adenocarcinoma of the pancreas in zebrafish and humans. (A) human 
pancreatic carcinoma (B) Zebrafish pancreatic carcinoma arose spontaneously in the 
offspring of an ethylnitrosourea (ENU)-mutagenized line. In both human and 
zebrafish pancreatic tissue, a mass of haphazardly arranged, irregularly shaped glands 
can be detected, along with nuclear pleomorphism and increased mitotic activity. The 
glands invade adjacent pancreatic tissue and induce a desmoplastic stromal reaction. 
All of these features are histological hallmarks of malignancy. Normal pancreatic 
tissue is visible at the top of the field (P). Insets show high-power views of neoplastic 























1.2.3 Techniques in studies of zebrafish cancer genetics. 
 
To study cancer genetics in zebrafish, a powerful approach is the creation of fish with 
alterations in specific cancer genes. To achieve this goal, several methods have been 
developed for genetic manipulation of zebrafish, including both forward and reverse 
genetic strategies. 
 
1.2.3.1 Forward genetics 
 
Forward genetics is also known as genetic screen, which is a procedure or test to 
identify and select individuals that possess a phenotype of interest. Since unusual 
alleles and phenotypes are rare, geneticists use a mutagen, such as a chemical or 
radiation, to generate mutations in chromosomes. In the early 1990s, it has been 
reported that ethylnitrosourea (ENU) can induce point mutations in the zebrafish 
genome (Grunwald et al., 1992) and large-scale forward genetic screens have been 
performed for developmental mutants. Approximately 2,000 genetic mutants have 
been generated by these screens with specific defects that affect virtually every aspect 
of embryogenesis (Fig. 2) (Driever et al., 1996; Eisen et al., 1996; E. Elizabeth Patton, 
2001). Forward genetics screens for zebrafish developmental defects have already 
revealed very interesting angiogenesis mutants related to cancers and subsequent 
screening for mutants relative to genomic instability and cell-cycle regulation have 
also been conducted. Viable mutants obtained in these screens can be further analyzed 




alters cancer incidence or tumour spectrum. 
 
Insertional mutagenesis is another forward genetic method which has been quite 
successful in zebrafish. In this approach, a mouse retrovirus is used as the mutagen 
and at least 500 mutants with an embryonic phenotype have been identified 
(Amsterdam et al., 1999; Golling et al., 2002). In these mutant zebrafish lines, 
Amsterdam et al. (2004) have identified 12 lines with elevated cancer incidence, 
which primarily develop malignant peripheral nerve sheath tumors (MPNSTs). It is 
found that 11 of the 12 lines were each heterozygous for a mutation in a different 
ribosomal protein (RP) gene, suggesting that although association of cancers with 
ribosomal genes in mammals is rare, many RP genes may act as haploinsufficient 
tumor suppressors in fish. A more recent study has showed that p53 is not synthesized 
apparently due to insufficient ribosomal proteins in the ribosomal protein gene 













Figure 2. Schematic representation of large-scale two-generation genetic screens. 
In F2 screens, a mutagen, such as ethylnitrosourea (ENU), is used to generate 
hundreds of point mutations in the male pre-meiotic germ cells (spermatogonia). 
ENU-treated males are crossed to wild-type females to produce the F1 heterozygous 
progeny. F1 fish are then crossed to siblings to create F2 families, half of which are 
genetically heterozygous for a specific mutation (m), whereas the other half are wild 
type. F2 siblings are crossed, and the resulting F3 progeny are 25% wild type (+/+), 
50% heterozygous (+/m) and 25% homozygous (m/m) for a recessive mutation. 
Together, the Boston and Tübingen screens, starting from about 300 ENU founder 
males, involved raising more than 5,000 F2 families, analysing more than 6,000 
mutagenized genomes and selecting more than 2,000 new developmental mutants for 















1.2.3.2 Reverse genetics 
 
Reverse genetics is an approach to discover the function of a gene by examining the 
possible phenotypes that may derive from a specific genetic sequence. Transgenic 
technology has been widely used in this area. Transgenic zebrafish are created by 
injecting a DNA construct into one-cell stage embryos. There are two transgenic 
approaches: transient transgenic expression and stable transgenic lines. The transient 
transgenic approach is to analyze gene expression and function immediately after the 
introduction of the foreign gene into embryos. Although this system is rapid and 
convenient, differential and mosaic gene expression from the same transgenic 
construct are frequently observed among injected embryos due to mosaic segregation 
of injected DNA during cleavage stage. In contrast to the transient transgenic 
expression system, stable transgenic lines refer to germline transmitted transgenic 
organisms. Offspring from the same transgenic founder usually present an identical 
pattern of transgene expression as the transgene is already stably integrated into the 
host genome. Therefore the approach of stable transgenic lines offers a large number 
of transgenic individuals with the same expression pattern in repeated analyses. In a 
microinjection experiment, typically, 50–75% of injected embryos express the 
transgene, while only 1–10% of these undergo stable germline transmission (Long et 
al., 1997; Picker et al., 2002). Given the optical clarity of zebrafish embryos, such 
transgenes are frequently coupled to a fluorescent protein tag such as green 




Langenau et al. (2003) have successfully established a transgenic zebrafish model 
which developed Myc-Induced T Cell Leukemia by expressing mouse c-myc under 
control of the zebrafish Rag2 promoter. 
 
In reverse genetics, there is another important technique which can help researchers to 
isolate zebrafish with specific gene disruptions called targeting induced local lesions 
in genomes (TILLING) (McCallum et al., 2000). TILLING is a method in molecular 
biology that allows directed identification of mutations in a specific gene. Specifically, 
ENU-mutagenized libraries of live fish or frozen sperm are screened for specific gene 
alterations. For example, researchers have used TILLING to identify zebrafish that 
carried a disruption in the rag1 gene (Wienholds et al., 2002) , which is a mediator of 
V(D)J recombination in lymphocyte and the TILLING strategy was also used to 
identify zebrafish with p53 mutations, so this technique could be applied to any 
cancer gene (Howard et al., 2003). 
 
1.2.3.3 Conditional transgenic systems in zebrafish. 
 
In transgenic zebrafish, if the oncogene is constitutively expressed, the transgenic 
lines could be prone to tumors or other diseases and the fish may not survive to sexual 
maturity to produce the next generation, making it difficult to maintain stable 
transgenic lines for further applications such as detailed characterization of tumor 




conditional gene activation systems are desired. Nowadays transgenic technology has 
been revolutionized by the development of techniques that allow temporal-spatial 
control of gene deletion or expression in transgenic animals. 
 
1.2.3.3.1 Tetracycline responsive system 
 
The tetracycline transactivator system has been established as a reliable tool for 
regulated transgene expression by pioneering work of Gossen (1992). Tetracycline 
repressor (tetR) is a protein that binds specifically to tetracycline operator (tetO) 
sequences within the promoter, rendering the gene transcriptionally silent. However, 
tetracycline can avidly binds tetR to relieve the repression. In this way, tetracycline 
resistance is controlled in a simple on/off manner by tetracycline itself (Gossen et al., 
1992). Afterwards, two modifications have been made to suit transgenic purposes. 
First, tetR has been converted into a transcriptional activator by fusing it with the 
activation domain of the herpes simplex virus VP16 protein, which is a virus-encoded 
factor that recruits cellular transcription factors and potently activates transcription in 
eukaryotic cells (Herr et al., 1998). This hybrid molecule is termed the tetracycline 
transcriptional activator (tTA). The second modification is the use of a 
cytomegalovirus (CMV)-derived minimal promoter, fused with tetO sequences to 
control transgene expression. All these form the original so-called ―tet-off‖ system, 
which means that the chimaeric promoter is inhibited by the presence of tetracycline. 




doxycycline (Dox, a derivative of tetracycline) and activates transcription (Gossen et 
al., 1995), which is called ―tet-on‖ system, meaning that the promoter is activated in 
the presence of tetracycline or doxycycline. The major advantage of the latter system 
is that gene induction occurs rapidly because the low levels of doxycycline required 
for transcriptional activation can be readily achieved. In contrast, the kinetics of gene 
induction by tTA is somewhat slower, since clearance of doxycycline can take days in 
animals. However, the original tet-on system has a low level of basal expression 
because rtTA retains some affinity for tetO sequences even in the absence of 
doxycycline, which may not be acceptable in some kind of experiment (e.g. 
expression of toxins). To overcome this problem, several attempts have been taken 
and finally the variant RtTA2s-M2 has been generated. This has virtually no 
background activity, enhanced doxycycline sensitivity and improved transcript 
stability (Urlinger et al., 2000a; Urlinger et al., 2000b). Finally, substitution of the 
VP16 moiety of rtTA with the transactivation domain of the mammalian transcription 
factor E2F4 appears to be tolerated better by mammalian cells (Akagi et al., 2001). 
Doxycycline and anhydrotetracycline, which are the analogues of the tetracycline and 
have higher tTA binding affinities and lower toxicities, tend to be used in preference 
to tetracycline itself (Gossen et al., 1993; Efrat S et al., 1995; A-Mohammadi et al., 
1997). For instance, Tet-on system using the cardiac myosin light chain 2 promoter in 
zebrafish has been reported by Chiu-Ju Huang
 
et al., 2005). They have compared 
various transactivators in the zebrafish fibroblast cell line, including tTA, rtTA, 




A                                 B 
 
Figure 3. Schematic outline of the Tet regulatory systems. (A) The mode of action 
of the Tc-controlled trans-activator (tTA). tTA, a fusion protein between the Tet 
repressor of the Tn10 Tc resistance operon from E. coli and the C-terminal portion of 
VP16 from herpes simplex virus, binds in the absence of the effector molecule 
doxycycline (Dox) to multiple tet operator sequences (tetO) placed upstream of a 
minimal promoter and activates transcription of gene x. Addition of Dox prevents tTA 
from binding and thus the initiation of transcription. (B) The mechanism of action of 
the reverse Tc-controlled trans-activator (rtTA). rtTA is identical to tTA with the 
exception of 4 amino acid substitutions in the TetR moiety, which convey a reverse 
phenotype. rtTA requires Dox for binding to tetO sequences in order to activate 



























-M2. All transactivators display a regulated capacity of 
activating luciferase expression and rtTA-M2 and the humanized rtTA2
S
-S2 mutant 
has the best performance in terms of increase of luciferase activity after induction.  
 
1.2.3.3.2 Cre-lox system 
 
The Cre-lox system is a useful genetic tool to control site specific recombination 
events in genomic DNA. The system consists of Cre recombinase and loxP sites. The 
Cre is originally a recombinase of the P1 bacteriophage directs recombination 
between loxP (locus of X-over P1) sites. Its function is to maintain phage-encoding 
plasmids as monomers. In other words, Cre is a site-specific DNA recombinase, 
which can catalyze the recombination of DNA between loxP sites in a DNA molecule. 
When cells that have loxP sites in their genome express Cre, a reciprocal 
recombination event will occur between the loxP sites, resulting in deletion, 
duplication, integration, inversion or translocation of sequences, according to the 
orientation of the recombination sites and the number of molecules involved. 
Specifically, for two loxP sites on the same chromosome arm, inverted loxP sites will 
cause an inversion, while a direct repeat of loxP sites will lead to a deletion event. If 
loxP sites are on different chromosomes, it is possible for translocation events to be 
catalysed by Cre induced recombination. This system has allowed researchers to 
manipulate a variety of transgenic organisms to control gene expression, delete 




the Cre/loxP recombination system in zebrafish, our lab has generated a stable 
transgenic zebrafish line by using a floxed (loxP flanked) GFP (green fluorescent 
protein) gene construct under the muscle-specific mylz2 promoter, and the new 
transgenic line expresses GFP reporter faithfully in fast skeletal muscles to the same 
intensity like our previous non-floxed GFP transgenic line under the same promoter. 
After injection of in vitro synthesized Cre RNA into embryos of floxed GFP 
transgenic zebrafish, a dramatic reduction of GFP expression has been observed, 
indicating the excision of floxed GFP transgene, as confirmed by the following PCR 
and sequencing information. Thus we have demonstrated that the Cre/loxP system can 
function efficiently and accurately in the zebrafish system.  
 
Another example of the application of Cre/LoxP system in zebrafish is from Dr. 
Thomas Look’s group. Previously, they have created a stable transgenic 
rag2:GFP-mMyc zebrafish line that develops GFP-labeled T cell acute lymphoblastic 
leukemia (T-ALL). However, this line can only be maintained by in vitro fertilization 
because the consistent myc expression makes T-ALL develop very rapidly. So they 
created a conditional transgene in which the GFP-mMyc oncogene is preceded by a 
floxed dsRED2 gene and have generated stable rag2:loxP-dsRED2-loxP-GFP-mMyc 
transgenic zebrafish lines, which have red fluorescent thymocytes and do not develop 
leukemia. By injecting Cre RNA into one-cell-stage embryos of the transgenic 
progeny of these lines, T-ALL can be induced to develop (Langenau et al., 2005). This 




1.2.3.3.3 GAL4-UAS system 
 
The GAL4-UAS system contains two parts: the GAL4 gene, which encodes the yeast 
transcription activator protein GAL4, and the UAS (Upstream Activation Sequence), a 
short section of the promoter region, to which Gal4 specifically binds to activate gene 
transcription. To utilize this system, GAL4 gene and UAS fused with gene of interest 
are separated into two transgenic lines. The GAL4 line is called the activator line, in 
which the GAL4 gene is placed downstream of a promoter of choice; the line with 
UAS is called the effector line, in which UAS is fused to a gene of interest and this 
gene is silent without the presence of the GAL4 protein. When the GAL4 (activator) 
line and UAS (effector) line are crossed, the expression of the gene of interest will be 
turned on in the double-transgenic progeny, following the expression pattern of GAL4 
in the activator line. The GAL4-UAS system has been routinely used in Drosophila 
(Fischer et al., 1988; Brand et al., 1993), and first tested in zebrafish by Scheer et al. 
in 1999, whose work indicates that the GAL4-UAS system works efficiently in 
zebrafish. 
 
1.2.3.3.4 Heat-shock inducible system 
 
Another strategy of conditional gene expression is to employ an inducible promoter, 
for example, heat-shock inducible promoter. The promoter of heat shock protein (hsp) 




varying the temperature and time of heat shock, the intensity and persistence of 
transgene expression can also be modulated. However, it is hard to control gene 
expression spatially because the transgene expression is induced ubiquitously in all 
cell types. In addition, the heat-shock promoters have a level of leaky expression 
which may produce unwanted effect. Furthermore, the expression profiles of target 
organisms would be affected by the heat shock itself, which again may produce 
unwanted effect. 
 
1.2.4   Zebrafish as a model for small-molecule screening 
 
As a good cancer model, zebrafish are also well-suited to whole organism-based 
small-molecule screens. Large numbers of tiny embryos can be arrayed in multi-well 
plates, along with compounds from a chemical library. For example, Peterson et al. 
tested 1,100 compounds from a small-molecule library and found that about 2% of the 
compounds were lethal and 1% caused a specific phenotype, after examining 
developmental defects of zebrafish embryos at days 1, 2 and 3 post-fertilization for in 
the central nervous system, the cardiovascular system, pigmentation and the ear 
(Peterson et al., 2000). These data show that highly potent and specific compounds 
can be identified using zebrafish as a screening tool. 
 
Furthermore, zebrafish can also be used in cancer drug discovery. Traditional drug 




of them represents the normal physiology of a multicellular organism. By using 
zebrafish embryos, the bioactivity of the compounds can be tested in a whole 
organism, and in cells that are undergoing normal cell–cell and cell–matrix 
interactions. Compounds that decrease cell proliferation, promote genomic stability, 
increase apoptosis or prevent angiogenesis could be good candidates as cancer drugs.  
 
1.2.5    Limitations of using zebrafish as a cancer model 
 
As disccussed above, although there are many advantages when zebrafish is used as a 
cancer model, there are some limitations as well. Firstly, it is reported that tumor 
incidences are relatively low in fish, which may be due to the effective anti-tumor 
immunity, the stability of its genome, well controled cell cycle, low body temperature 
and the absence of the lymph drainage and lymph nodes, etc. (Ivan, 2004). Secondly, 
tumor spectra are sometimes different when compared with that of mice and humans. 
It has been reported that bony fish are prone to such neoplasms as lymphoma, 
nephroblastoma, melanoma and hepotama (Ivan, 2004). Thirdly, there are some 
differences between human and zebrafish cancers as well. For example, zebrafish do 
not have mammary tissue or a prostate gland, and have gills instead of lungs. 
Although zebrafish might not be a direct model for breast, prostate or lung cancer, it is 
possible that pathways involved in zebrafish tumorigenesis will be applicable to these 
human neoplasms. Another difference is that zebrafish carcinomas rarely, if ever, 




invasion into other organs (Howard et al., 2003). 
 
1.3   Oncogene utilized in the transgenic lines 
1.3.1 Xmrk oncogene 
1.3.1.1 The Xiphophorus melanoma model 
 
Xmrk, which stands for Xiphophorus melanoma receptor kinase, is first identified in 
the melanoma system of the fish Xiphophorus. Melanoma is a malignant tumor of 
melanocytes, which are pigment cells with uncontrolled growth. It is predominantly 
found in skin, but incidences in the bowel and the eye are also reported. As one of the 
most aggressive forms of human cancer, it has the fastest increase in incidence of all 
tumors and it accounts for 75 percent of all deaths associated with skin cancer. 
However, the mechanisms accompany the transformation of a normal pigment cell to 
a melanoma cell are poorly understood, making appropriate melanoma models so 
important. 
 
In fish of the genus Xiphophorus, melanoma development can be induced by 
generating a regulatory imbalance between a dominant tumour-inducing locus (Tu) 
and a Tu-repressing regulatory locus (R), which are located on different chromosomes 
in Xiphophorus maculates (platy fish). The receptor tyrosine kinase (RTK) gene Xmrk 
is the oncogenic determinant encoded by the Tu locus, which is found in the 




Tu on different chromosomes is validated. However, in another genus, the swordtail 
Xiphophorus hellerii, Both Tu and R (or at least an allele of R able to suppress the 
oncogenic action of Tu) are absent. So when X. maculatus are crossed with X. hellerii, 
F1 progeny are heterozygous for both R and Tu, and further crossing of these F1 
animals with X. hellerii produces 25% offspring heterozygous for the Tu locus, but 
devoid of R (Gordon et al., 1927; Anders et al., 1978; Schartl et al., 1995). In this 
situation, Tu is out of control in the pigment cell lineage, where it is overexpressed 
and performs its oncogenic function. This results in the formation of highly malignant, 
invasive and exophytic melanomas which are fatal to the fish. However, melanoma 
formation can be completely suppressed in the subsequent generations when R is reintroduced 
by crossing melanoma-developing backcross hybrids to platy fish, indicating that no 
additional genetic alterations occurred in the tumor induction process. 
 
According to these genetic data, it seems that the activity of Tu alone is sufficient to 
cause cancer, which is not very consistent with the common multi-step theory of 
tumor formation. It is generally believed that cancer is a multistep process of 
successive somatic genetic and epigenetic alterations (Vogelstein et al., 1993). 
Growth advantages might be given by mutational activation of oncogenes or 
inactivation of tumor suppressor genes; however, further changes are also needed to 
enable unrestricted tumor growth, invasion and metastasis. The accumulation of 
tumorigenic genetic changes is often caused by a genomic instability that is frequently 




melanoma, it is showed that the frequency of microsatellite instability was low (7.6% 
over a total of 263 loci), indicating that genomic instability is not a relevant 
component of the mechanisms underlying melanoma formation in Xiphophorus 
hybrids (Zunker et al., 2006). These data raise the hypothesis that activating the Tu 
locus alone is sufficient to progress from the first step of neoplastic transformation of 
a melanocyte to full-blown cancer. Thus, how does it work and how can it bring about 
all the necessary steps to the transformation of a normal pigment cell into a highly 
malignant melanoma cell? The answer comes from the molecular nature of the 
oncogene at the Tu locus. 
 
1.3.1.2 The Xmrk oncogene in the Tu locus 
 
Positional cloning has revealed that Xmrk is the gene responsible for tumour 
development at the Tu locus, encodes a subclass I receptor tyrosine kinase belonging 
to the epidermal growth factor receptor (EGFR) family. Disruption of this gene can 
cause the loss of function with respect to melanoma formation (Schartl et al., 1999; 
Wittbrodt et al., 1989). 
 
The EGFR is the cell-surface receptor for members of the epidermal growth factor 
family (EGF-family) of extracellular protein ligands. In nematodes and flies, only one 
EGFR-like gene has been described, and mammals and birds have four genes: EGFR 




HER4 (erbB4). However, fish have generally at least seven EGFR-like genes, 
including two egfr (egfra and egfrb), two erbb3 and two erbb4 genes. The Xmrk 
oncogene was generated from a tandem gene duplication of egfrb (formerly called 
INV-Xmrk). There are only 14 amino acid differences over about 1165 amino-acid 
residues, so both proteins are almost identical. The new copy was fused to a different 
5’ region (Adam et al., 1993; Volff et al., 2003), and this might have altered the 
transcriptional control of the copy. This might be one interpretation for the 
tumor-inducing activity of the Xmrk oncogene in hybrids. In the hybrids, Xmrk is 
highly expressed in the transformed pigment cells rather than in other cells. Therefore, 
a pigment-cell-specific transcriptional deregulation might be the primary event of 
melanoma formation. 
 
In the extracellular domain of the growth factor receptor that occurred after 
duplication of the protooncogene, two mutations might account for the oncogenic 
properties of Xmrk. Both amino acid changes cause ligand independent intracellular 
signaling (Gomez et al., 2001). The first mutation is Cys555 to Ser555. In the 
proto-oncogene, Cys555 forms an intramolecular disulfide bridge with Cys564, so 
this C555S mutation generates a free Cys564, thereby disturbing the intramolecular 
cysteine bridge while enabling Cys564 residue to bind with its counterpart from a 
second monomer (Meierjohann et al., 2006a). The distance between the intracellular 
domains of both monomers is reduced by the dimerization and cross-phosphorylation 




are the result of binding of the growth factor ligand. The second mutation is Gly336 to 
Arg336, which also leads to receptor activation, but the mechanism is unknown. The 
activated Xmrk protein then constitutively sends out a growth factor receptor signal, 
which leads to a variety of cellular responses that determine the neoplastic phenotype 
of the melanoma cells. 
 
1.3.1.3 Oncogenic signal transduction of Xmrk 
 
The main effectors of Xmrk-induced proliferation, anti-apoptosis and cell motility, are 
already known. As a fish orthologue of the well-studied mammalian EGFR, Xmrk 
uses a number of pathways that have been well known for EGFR signaling in other 
organisms from Caenorhabditis elegans to human. The EGF receptor (and 
consequently also Xmrk) is a member of the receptor tyrosine kinase family. Their 
kinase domain, which is located in the intracellular domain of the protein, can 
phosphorylate specific tyrosine residues of nearby proteins, including the intracellular 
domains of the second receptor monomer in a dimerized protein. Additionally, several 
C-terminal residues are phosphorylated and serve as docking sites for the SH2 
(Src-homology 2) domains of numerous downstream proteins that are subsequently 
activated by the kinase. Activation of the transcription factor STAT5 (signal 
transducer and activator of transcription 5) brings about both proliferation and 
anti-apoptotic events, while the latter is in cooperation with the phosphatidylinositol 




al., 2000). Xmrk also activates the Ras–Raf–MAPK (mitogenactivated protein kinase) 
pathway, which affects proliferation. Differentiation is also affected by reducing the 
stability of the pigment-cell-specific transcription factor MITF (microphthalmia 
transcription factor), and the survival of tumor cells at ectopic sites is affected by 
inducing the transcription of osteopontin
 
(Delfgaauw et al., 2003; Geissinger et al., 
2002; Wellbrock et al., 1999). Xmrk can also strongly activate the tyrosine kinase Fyn, 
which plays at least two roles in transformation: first, it augments the 
above-mentioned MAPK-dependent effects by maintaining increased levels of 
activated MAP kinases; second, in cooperation with the focal adhesion kinase (FAK), 
fyn mediates cell migration (Meierjohann et al., 2006b; Wellbrock et al., 2002) 
(Fig.4). Altogether, analysis of the molecular signaling pathways induced by Xmrk 
reveals that the essential steps in tumor development and might provide an insight 
into the basic principles of this disease.  
 
1.3.1.4 Xmrk oncogene in transgenic animal models 
 
A recent paper by Winnemoeller et al. has described the function of Xmrk in medaka 





Figure 4. Known signaling pathways of Xmrk that induce different 
characteristics of the neoplastic phenotype. Xmrk is a member of the receptor 
tyrosine kinase family. Their kinase domain is located in the intracellular part of 
the protein and is responsible for phosphorylating specific tyrosine residues of 
nearby proteins, including the intracellular domains of the second receptor 
monomer in a dimerized protein. In addition to the kinase domain itself, several 
C-terminal residues are phosphorylated and serve as docking sites for the SH2 
(Src-homology 2) domains of numerous downstream proteins that are subsequently 
activated by the kinase. By recruiting and activating several proteins such as 
kinases, transcription factors and adaptor proteins, Xmrk induces the pathways that 
are required for transformation. Analysis of the molecular signaling pathways 
induced by Xmrk reveals that the essential steps in tumor development, namely 
blocking of cell differentiation, activation of unrestricted proliferation, protection 
from apoptosis, and induction of migration, are all induced solely by Xmrk. 













constructs were made for microinjection: (1) CMV:egfp construct as a control; (2) 
CMV-TK:egfrb construct to test the proto-oncogene of Xmrk (3) 
CMV-TK:egfrb-C555S construct to test one mutation of egfrb (4) 
CMV-TK:egfrb-G336R construct to test another mutation of egfrb (5) CMV:Xmrk 
construct to test the function of Xmrk. In the CMV-Tk:egfrb group, only 4 out of 171 
embryos developed epithelial hyperproliferation, which became apparent as epidermal 
cysts, and these lesions never grew out to solid tumors or showed any sign of 
malignancy. When even higher amounts of egfrb constructs were injected (up to 
10-fold, approximately 250 pg DNA, the maximum of transgene DNA that is tolerated 
by the Medaka embryo), solid tumors like with the C555S, G336R and Xmrk 
constructs were observed. This confirms that even when expressed at the same level 
as Xmrk, the egfrb gene of Xiphophorus does not act as an oncogene. However, when 
egfrb is highly overexpressed, tumors are induced. This is consistent with what we 
know in mammalian cancers, where overexpression of not mutationally altered EGFR 
family RTK causes tumor formation (Holbro et al., 2003). In the latter 3 groups, both 
mutations and Xmrk led to a high rate of tumor formation. These tumors were 
classified as epithelial hyperproliferation or solid tumors that occurred in the 
developing brain, the embryonic retina and the integument. Interestingly, after 
injection into Medaka embryos the C578S mutation was significantly less tumorigenic 
than the G359R mutation. It seems as if the G359R mutation creates receptor dimmers 
that are more active or more stable. All together, they showed that subtle point 




1.3.2 MYC oncogene 
1.3.2.1 The discovery of MYC 
 
As early as in 1911, Peyton Rous observed that chicken sarcoma could be transmitted 
through cell-free extracts from the tumors, indicating that an entity might be the 
etiologic agent of these sarcomas. Later on a retrovirus, now known as the Rous 
sarcoma virus (RSV), was shown to be the infective agent. In 1970, the identification 
and purification of reverse transcriptase provided an essential tool for the isolation of 
the transforming sequences from RSV. Studies of a specific subgroup of avian 
retrovirus, which induces myeloid leukemia, sarcomas, liver, kidney, and other tumors 
in chickens, led to the identification of the gene and later named myc, for 
myelocytomatosis (the leukaemia caused by this virus). However, the same gene 
sequences were also identified in the DNA of non-infected cells, and a theory 
developed: oncogenic avian retroviruses commonly capture cellular growth regulatory 
genes and transmit the activated gene (viral oncogene).  
 
In human, MYC gene was first discovered in Burkitt's lymphoma patients. Cancer 
cells in Burkitt's lymphoma always show chromosomal translocations, and by cloning 
the break point of the fusion chromosomes, a gene was identified and it was similar to 






1.3.2.2 The structure and function of MYC 
 
MYC protein belongs to MYC family of transcription factors, which also includes 
MYCN and MYCL genes and they contain bHLH/LZ (basic Helix-Loop-Helix/ 
Leucine Zipper) domain. The basic domain can bind to DNA while the HLH region 
and leucine zipper domain allow the dimerization with its partner Max, another bHLH 
transcription factor. The human MYC is located on human chromosome 8q24, 
consisting of three exons with three promoters. Translation starting at the AUG site in 
the second exon produces a major 439 amino acid, 64 kDa C-MYC protein. There are 
several highly conserved regions between MYC, MYCN and MYCL, which are termed 
MYC homology boxes, and these different domains are required for specific functions. 
Expression of MYC in the normal cell is tightly regulated by external signals, such as 
growth factors and extracellular matrix contacts, as well as by internal clocks, such as 
the cell cycle. The resting cell and proliferating cell have quite different MYC 
expression patterns: the resting cell normally expresses little MYC, while cells 
stimulated by growth factors dramatically increase MYC expression as an immediate 
early response gene. If abnormal or ectopic overexpression of MYC in a cell happens, 
protective pathways such as the induction of p19/p14ARF and a p53-dependent cell 
death pathway might be activated, by which cells that overexpress c-myc are 
eliminated from the host organism through apoptosis and the organism is protected 
from lethal neoplastic changes. Regulated expression of MYC is required for normal 




deleted by homologous recombination die at embryonic day 9.5 with a lack of 
primitive hematopoiesis (Davis et al., 1993). Mycn knockout was similarly lethal at 
embryonic day 10.5, while, curiously, Mycl1-null mice are viable (Pirity et al., 2006). 
These observations also suggest that those MYC genes also play important roles in 
early development. 
 
1.3.2.3 Myc oncogene in transgenic animal models 
1.3.2.3.1 Myc in transgenic mouse models 
 
In human hepatocellular carcinoma (HCC), co-expression of transforming growth 
factor (TGF)-α and MYC protooncogenes has been frequently detected, indicating 
an important role for these genes in the malignant growth of the liver (Thorgeirsson et 
al., 2002). To investigate the function of MYC and TGF- α in mammals, 
Santoni-Rugiu et al. (1996) have generated cMyc and cMyc/TGF-αtransgenic mice, 
which over-express cMyc and/or TGF-αin mouse liver and have shown that hepatic 
expression of cMyc alone results in chronic hepatic proliferation and increased 
incidence of liver cancer, while co-expression of cMyc and TGF-α transgenes in the 
liver accelerates HCC development in cMyc/ TGF-α double transgenic mice when 
compared with both parental lines. For example, in the cMyc/TGFα double 
transgenic line, rapid progression from early preneoplastic focal lesions to HCC 
occurred in 4 months, with 100% frequency of HCC by 8 months and survival 




longer tumor latency as well as decreased incidence of HCC. These data indicate that 
the molecular mechanisms of hepatocarcinogenesis in cMyc and cMyc/ TGF-α 
transgenic mice might be different.  
 
Alix et al. (1999) have investigated the role of apoptosis in tumor development by 
studying the effect of Bcl-2 gene expression on cMyc/Bcl-2 double transgenic mice. 
While constitutive cMyc gene overexpression in the liver resulted in cellular 
hepatocarcinoma, the co-expression of the Bcl-2 gene inhibited the emergence of liver 
tumors, by inhibiting a pretumoral phase characterized by increased proliferation and 
apoptosis. These indicate an in vivo tumor suppressor effect of Bcl-2 during the early 
stages of hepatic carcinogenesis for the first time. 
 
Catherine et al. (2004) have reported that inactivation of the MYC oncogene is 
sufficient to induce sustained regression of invasive liver cancers. In their experiment, 
inactivation of MYC led to a mass of tumor cells differentiating into hepatocytes and 
biliary cells to form bile duct structures. Meanwhile, the expression of the tumour 
marker α-fetoprotein disappears rapidly while the increase of expression of liver cell 
markers cytokeratin 8 and carcinoembryonic antigen, as well as the liver stem cell 
marker cytokeratin 19 in some cells was observed. By in vivo bioluminescence 
imaging, they found that many of these tumour cells remained dormant as long as 
MYC remain inactivated; however, MYC reactivation immediately restored their 




restored tumour retained the identical molecular signature by array comparative 
genomic hybridization, which indicates that these cells were clonally derived from the 
tumour cells. Therefore, they proposed that oncogene inactivation may reverse 
tumorigenesis in the most clinically difficult cancers. 
 
1.3.2.3.2 cMyc in transgenic zebrafish models 
 
Recently, cMyc has also been studied in the zebrafish model for its oncogenic 
potential. Based on the knowledge that MYC is involved in the development of B- and 
T-cell neoplasms in mice, chickens, and humans, they created a DNA construct using 
mouse cMyc (mMyc) under control of the zebrafish rag2 promoter (zrag2), which 
targets gene expression specifically to lymphoid cells (Langenau et al., 2003; Jessen 
et al., 2001). 11(5%) of 215 mosaic fish developed tumors. Then Langenau et al. have 
created a second transgenic fish line using mMyc/GFP fusion under control of the 
same promoter zrag2, and 7 (6%) of 122 fish developed tumors, which shows a 
similar rate and the tumours are labeled by GFP, so it could be observe in live fish. 
Leukaemic cells are harvested from the transgenic fish and were injected into the 
peritoneum of wild-type recipients that had been irradiated at sublethal levels. At the 
site of injection, GFP-positive tumours were evident seven days after injection, and by 
14 days had spread extensively throughout the peritoneum, which verified the 
malignant nature of the T-cell neoplasm and demonstrated that tumour growth can be 




Since mMyc oncogene is constitutively expressed in this stable rag2:EGFP-mMyc 
transgenic zebrafish line, T-ALL develops very rapidly and this line can only be 
maintained by in vitro fertilization. Thus they created a conditional transgenic line: 
rag2:loxP-dsRED2-loxP-EGFP-mMyc transgenic zebrafish lines, in which the 
EGFP-mMyc oncogene is preceded by a floxed dsRED2 gene. These lines have red 
fluorescent thymocytes and do not develop leukemia; however, by injecting Cre RNA 
into one-cell-stage embryos, transgenic progeny from one of these lines can be 
induced to develop T-ALL (Langenau et al., 2005a).  
 
Since bcl-2 is reported to suppress apoptosis and even to inhibit the emergence of 
cMyc induced tumors in liver (Alix et al., 1999), Thomas Look’s group also 
investigated the function of the zebrafish bcl-2 homolog by using 
Tg(rag2:EGFP-bcl-2) transgenic fish. By comparison using fluorescent microscopic 
analysis of living Tg(rag2:EGFP-bcl-2) and Tg(rag2:GFP) transgenic fish, it is 
showed that their thymocytes in Tg(rag2:EGFP-bcl-2) lines were resistant to 
irradiation- and dexamethasone- induced apoptosis. They also compared the 
responsiveness of mMyc-induced leukemias with and without EGFP-bcl-2 expression 
in living transgenic zebrafish. T-cell leukemias induced by the Tg(rag2:EGFP-mMyc) 
transgene could be ablated by irradiation; however, leukemias in double transgenic 
fish expressing both mMyc and EGFP-bcl-2 were resistant to irradiation-induced 
apoptotic cell death. Therefore, this might be an ideal transgenic line to study 




In their previous Tg(rag2:loxP-dsRED2-loxP-EGFP-mMyc) transgenic zebrafish lines, 
after injection of Cre RNA into the fertilised egg, the disease penetrance is very low 
(13%), maybe due to suboptimal recombination. Thus, they developed a novel system: 
double-transgenic zebrafish express lox-dsRED2-lox-EGFP-mMyc in developing 
lymphocytes and Cre under a heat-shock inducible promoter. After heat-shock, the 
Cre expression could be activated, then the lox-dsRED2-lox cassettes could be excised, 
and the EGFP-mMyc expression is turned on. Upon an optimal heat-shock treatment, 
a much higher penetrance of tumour induction (81%) was achieved, and this might be 
an ideal model for mechanistic studies of tumorigenesis as well as forward genetic 
screens (Hui Feng et al., 2007).  
 
1.4   Main objectives and significance of the study 
 
In the past few years, our laboratory has been developing the zebrafish model for 
investigation of liver cancers. By generating transgenic zebrafish lines with several 
oncogenes specifically expressed in the liver, we aimed at investigating their potency 
in generation of liver tumors as well as the mechanisms of cancer development. Two 
oncogenes were tested in this study, mouse c-myc (mMyc) and Xiphophorus 
melanoma receptor kinase (Xmrk), and three types of transgenic lines were generated 
in the present study. I am involved in molecular and biological characterization of 
these transgenic lines with the aim to identify an effective oncogene transgenic line 




this kind in zebrafish. 
 
The specific aims for characterizing these three types of transgenic lines are 
summarized as follows:  
1) Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic zebrafish lines. The aim of using these 
transgenic lines is to test the function of mouse c-myc (mMyc) oncogene in 
zebrafish liver, as well as the popular conditional expression system—Tet-on 
system. The expression of oncogene mMyc could be turned on with the presence 
of Doxycycline (Dox) and turned off when Dox is withdrawn. The expression of 
mMyc in Tet-on transgenic lines will be examined and the abnormal and/or tumor 
phenotypes of fish expressing oncogenes will be monitored. 
2) Tg(mvtg1:mMyc-GFP) transgenic zebrafish lines. In these transgenic lines, 
oncogene mMyc is tested, under the control of mvtg1 (medaka vitellogenin1) gene 
promoter. Vitellogenins are precursors of egg yolk proteins and are normally 
synthesized only in the liver of adult females in oviparous vertebrates under the 
control of the female hormone. vtg mRNA expression can also be induced in male 
fish by estrogen. Therefore, we expect to establish a novel inducible system by 
using mvtg1 promoter, in which the expression of oncogene mMyc could be 
controlled by the presence or absence of estrogen. In this study, we aim to test the 
function of the medaka mvtg1 promoter in transgenic zebrafish as well as the 
potential of oncogene mMyc in liver tumorigenesis in zebrafish. 




Xmrk is under the control of lfabp (liver fatty acid binding protein) gene promoter, 
which leads to constitutive Xmrk expression in zebrafish liver. The expression of 
Xmrk in these transgenic lines as well as changes in phenotype, survival rate and 
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2.1   Maintenance of zebrafish and embryos 
 
Zebrafish were maintained basically according to the method described by 
Westerfield (1994). The fish embryos was raised up in egg water (5 mM NaCl, 0.17 
mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, 0.0001% Methylene Blue) in a 28.5℃ 
incubator till 4-5 days post fertilization (dpf), and then transferred to a 2.5-L tank with 
0.5 L egg water. Normally, the fish larva was fed twice per day with flake foods 
(Aquori, USA) and Artimia nauplia till one month. The juvenile fish after one month 
old were transferred to 10-L containers of the Aquatic Habitats stand-alone System 
(Aquori, USA), and fed with red blood worms twice a day. During the spawning 
period, the fish were fed with brine shrimps (World Aquafeeds, USA) and were kept 
under the photoperiod cycle set at 14 hours of day (light) and 10 hours of night (dark). 
In the afternoon of the day before embryo collection, pairs of male and female fish 
were put in a mating tank with an inner sieved container and separated by a spacer. In 
the next morning, embryos were collected in the bottom of matting tank after placing 
the paired fish for breeding by removing the spacer. 
 
2.2   Preparation of plasmid DNAs 
2.2.1 Retransformation 
 
Competent cells were prepared for transformation of plasmid DNA. To prepare 
competent bacterial cells, 2 ml of LB broth was inoculated with a single fresh colony 
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of Escherichia Coli DH5 and incubated at 37℃ overnight with shaking at 250 rpm. 
In the following morning, 0.5 ml of overnight culture was re-inoculated into a 500-ml 
flask containing 100 ml of LB broth and shaken at 250 rpm at 37℃ until its OD600 
reached around 0.5. The culture was chilled on ice for 15 min and cells were pelleted 
by centrifugation at 1,000 g at 4℃for 15 min. The pelleted cells were drained 
thoroughly and resuspended in 30 ml of buffer RF1 (100 mM RbCl, 50 mM 
MnCl2·4H2O, 30 mM potassium acetate, 10 mM CaCl2·2H2O, 15% glycerol) with 
moderate vortexing. After incubation on ice for 15 min, the cells were pelleted and 
resuspended in 8 ml of buffer RF2 (10 mM MOPS, 10 mM RbCl, 75 mM 
CaCl2·2H2O, 15% glycerol). After another 15 min of incubation on ice, the competent 
cells were transferred into 1.5-ml microcentrifuge tubes in aliquot of 100 μl and 
stored at -80℃. The frozen stock was used for subsequent transformation reactions. 
 
0.5-1 μl plasmid DNA was added into 100 μl of E.Coli DH5 competent cell. This mix 
was then incubated on ice for 20 min. After being shocked by heating at 37℃ for 1.5 
min, the tube was cooled immediately on ice for 5 min. 1 ml of LB medium was then 
added to the transformation mixture, and it was incubated at 37℃ for 1 hour with 
shaking at 200 rpm. Subsequently, bacterial were concentrated by brief centrifugation, 
the whole bacterial pellet was resuspended in 100 μl of LB and spread onto LB plates 
supplemented with appropriate antibiotic (50 μg /ml ampicillin in this case). The 
plated were incubated at 37℃ overnight. Positive clones were identified by PCR and 
inoculated into 4-6 ml LB medium at 37℃ overnight. 
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2.2.2 Minipreparation of plasmid DNA. 
 
To measure the absolute concentration of zvtg1 and mMyc mRNA in 
Tg(mvtg1:cMyc-GFP) transgenic line 30, plasmid A248 (a cDNA clone of zebrafish 
vitellogenin 1 gene from the previous work of our lab, Gong et al., 1997) and plasmid 
lfabp-mMyc-GFP were prepared using Wizard Miniprep Kit (Promega, USA). These 
two plasmids are used later as samples to make the standard curves in quantitive 
real-time PCR essays. 
 
Typically, around 20-30 μg of plasmid DNA could be isolated from 4-6 ml of 
overnight bacteria culture in Luria-Bertani(LB) medium. The 6-10 ml overnight 
culture in LB medium with appropriate antibiotic was harvested by centrifugation at 
10,000 rpm for 5 min in an Eppendorff microcentrifuge (Germany). The bacterial 
pellet was resuspended in 250 μl of Cell Resuspension Solution (100 μg/ml RNase A; 
10 mM EDTA; 50 mM Tris, pH7.5). 250 μl of cell Lysis Solution (0.2 M NaOH; 1% 
SDS) was added to the bacteria suspension and mixed by gently inverting the tube 
several times. Then 10 μl of alkaline protease (10 mg/ml) was added and incubated at 
room temperature for 5 min. This mixture was then neutralized by adding 350 μl of 
Neutralization Buffer (1.32 M KOAc, pH4.8). After being centrifuged at the top speed 
for 10 min, the supernatant was transferred into a fresh Minicolumn in a 2-ml 
collection tube and centrifuged at the top speed for 1 min, followed by washes with 
750 μl of Wash Solution (80 μM KOAc; 40 μM EDTA; 8.3 mM Tris-HCl, pH7.5; 55% 
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ethanol) once for 1 min, and then with 250 μl of Wash Solution once by centrifuge at 
top speed for 2 min. The Minicolumn was then transferred to a new eppendorff tube. 
50 μl of water was added to the Minicolumn. After 1 min incubation at room 
temperature, plasmid DNA was eluted from the Minicolumn by centrifugation at 
14,000 rpm for 1 min. 
 
2.3   RNA preparation 
2.3.1 RNA extraction 
 
Total RNAs from zebrafish embryos and different adult tissues were extracted using 
TRIzol reagent (Invitrogen, USA). Zebrafish tissues and embryos were quickly frozen 
in liquid nitrogen and homogenized in TRIzol reagent (100 mg tissues/ 1 ml TRIzol 
reagent). The homogenate was incubated at room temperature for 5 min to allow 
nucleoproteins to dissociate and then 200 μl of chloroform was added. The mixture 
was vortexed vigorously for 15 sec and incubated at room temperature for 3 min. 
They were then centrifuged at 12,000 g for 15 min at 4℃ to separate aqueous and 
organic phases. 300 —500 μl of aqueous phase was transferred to a new tube and an 
equal volume of isopropanol was added. After incubation in ice bath for 30 min, RNA 
was pelleted by centrifugation at 12,000 g for 10 min at 4℃. The pellet was washed 
with 1 ml of cold 70% ethanol (in DEPC water). After drying pellet at room 
temperature completely, the RNA pellet was then dissolved in DEPC (diethyl 
pyrocarbonate) treated water and stored in -80℃. 
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2.3.2 Measurement of RNA concentration 
 
RNA was quantified by optical density reading at 260 nm and 280 nm using UV-1601 
spectrophotometer (Shimadzu, Japan). One unit of OD260 is equivalent to 40 μg/ml of 
RNA, and OD260/OD280 ratio > 1.9 indicates good quality of RNA product. 
 
2.3.3 Formaldehyde RNA gel electrophoresis 
 
The isolated RNA samples were analyzed through gel electrophoresis of 1.2% agarose 
gel in 10% MOPS buffer and 17% formaldehyde. 20 μg of isolated total RNA of adult 
tissues or 10 μg of embryonic and organ specific tissues were loaded into each lane. 
RNA samples were mixed with 10 μl of formamide, 4 μl of 37% formaldehyde, 2 μl 
of 10×MOPS and 0.1 μl of ethidium bromide to a total volume of 20 μl. RNA was 
heated at 65℃ for 10 min before loading with loading buffer (0.4% bromophenol 
blue, 6% sucrose in water). The gel was run in 1×MOPS buffer with 3% 
formaldehyde running buffer at 70 mV for 3 hrs until the dye moved near the end. 
After electrophoresis, the gel was rinsed in distilled water. The gel was visualized on a 
312 nm UV box (Model TF-35M UV transilluminator Vilber luormat, France). 
 
2.4   Reverse transcription of RNA to cDNA 
 
RNA samples were reverse transcribed to cDNA using SuperScripte
TM Ⅱ RT 
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(Invitrogen) and real-time PCR was conducted using LightCycler DNA amplification 
kit SYBR Green Ⅰ (Roche Applied Science) according to the manufacturer’s 
instruction manual with minor modifications. Briefly, 2 μg of total RNA was mixed 
with 2 μl of Oligo (dT) (0.5 μg/ml), 2 μl of dNTP (10 mM each) and sterile water to 
make up 20 μl of total volume. The mixture was heated at 65℃ for 5 min and quickly 
chilled on ice. Then 8 μl of 5×First-Strand Buffer, 4 μl of 0.1 M DTT, and 1 μl of 
RNaseOUT (Invitrogen) (40 units/μl) were added into the previous mixture and 
incubated at 42℃ for 50 min. To inactivate the reaction, the previous reaction 
product was heated at 70℃ for 15 min. The synthesized first-strand cDNA was 
diluted at least for 10 times before it could be used as template in real-time PCR. 
 
2.5   Polymerase chain reaction 
 
A typical PCR was performed using PTC-200 thermal cycler (MJ Research, USA). 
Each 25 μl of PCR reaction contained 2.5 μl of 10×PCR buffer (1×=10 mM 
Tris-HCl, pH 9.0; 50 mM KCl; 0.1% Triton X-100), 3 μl of 25 mM MgCl2, 1 μl of 2 
mM dNTP mixture (2 mM dATP, 2 mM dCTP, 2 mM dGTP, 2 mM dTTP), 0.5 μl of 
0.2 μg/μl antisense primer, 0.5 μl of 0.2 μg/μl sense primer, 0.2 μl (1 unit) of Taq 
DNA polymerase (Promega), and 100 ng~400 ng of template DNA. The cycling 
condition was as follows: 94℃, 5 min; 30 cycles of 94℃, 30 sec, 55~62℃, 1 min, 
and 72℃ 45 sec~1.5 min; and finally 72℃, 10 min. All PCR products were analyzed 
on 1% agarose gel with 0.5 μg/ml ethidium bromide in 1×TAE buffer and visualized 
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on 312 nm UV box (Model TF-35M UV transilluminator Villber Lourmat, France)). 
The photo was taken with the Unvitech Gel Document system (Uvitech Co.) and 
printed from a thermal-paper printer.  
 
2.6   One-Step reverse transcription PCR 
 
QIAGEN One-Step RT-PCR kit (QIAGEN) was used for RT-PCR analysis. The 
RT-PCR primers were designed to span an intron/exon boundary in order to avoid 
amplifying genomic DNA, or can be designed to flank an intron to distinguish 
genomic amplification (large fragment) from cDNA amplification (small fragment). 
The reaction mix was set up in 25 μl volume: 5 μl of 5×RT-PCR buffer, 1 μl of 
dNTPs mix (containing 10 mM of each dNTA), forward primer 0.3 μM (final 
concentration), reverse primer 0.3 μM (final concentration), 1 μl of one-step RT-PCR 
enzyme mix, and 0.5~1 μl of template RNA (1 μg/μl). The PCR program included 
reverse transcription at 50℃ for 30 min and initial PCR activation at 95℃ for 15 
min, followed by 3 step cycling: 94℃ 0.5~1 min, 50~68℃ 0.5~1 min, 72℃ 1 min, 
for 25~32 cycles, and then 72℃ 10 min for final extension. The reaction mix was 
kept on ice till the thermal cycler reached 50℃, and then was placed in the thermal 
cycler and carried on the RT-PCR reaction. The primers used for one-step RT-PCR are 
listed. The primers used in this study are listed below. 
 
 






mMyc Forward: 5’-AAACGACAAGAGGCGGACAC-3’ 
Reverse: 5’-AATGGACAGGATGTAGGCGG-3’ 
Xmrk Forward: 5’-ATTGCGGCCGCCATGGAGTTTCTGCGCGG-3’ 
Reverse: 5’-GGTTCTAGATTCTAGCGGACAGGAGTGTACC-3’ 
cad Forward: 5’- AGGGACAGCATGCTATTTGG -3’ 
Reverse: 5’- CCATTTTCAGCGACATGACT -3’ 
cdc2 Forward: 5’- AAGCAAGCAATGTGAGCGTA -3’ 
Reverse: 5’- CCACCCAGTTGACAAACAAA -3’ 
cyclin
A1 
Forward: 5’- TGCAGCGCTTGAGTCTATTG -3’ 
Reverse: 5’- GGCAACATACAGCCTTCACA -3’ 
cyclin
E 
Forward: 5’- TCGCTCTATGCGACTTGAGA -3’ 
Reverse: 5’- CCTGTCAGGATTTTGCTGGT -3’ 
elf4e1
a 
Forward: 5’- TGGCTCTGTTGCAAAGACTG -3’ 
Reverse: 5’- TCCATAAGCACCCATGTTCA -3’ 
ldha Forward: 5’- AGACCTTGTGGGGTGTTCAG -3’ 
Reverse: 5’- TCTGCGAGTGACATGGAGTT -3’ 
odc Forward: 5’- GCTCAACCAAACCTGCTCTC -3’ 
Reverse: 5’- GAAGTCCTCGCTCAAGCATC -3’ 
zvtg1 Forward: 5’-GGATTCCAGAGATCACAATGT-3’ 
Reverse: 5’-CAGTACAGCAGTGGTCTAAT-3’ 
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2.7   Whole mount in situ hybridization on zebrafish larva 
2.7.1 Probe synthesis 
 
About 5 μg of plasmid DNA was linearized at the 5’ end of the cDNA insert by 
restriction enzyme digestion at 37℃ for 2 hours. The digestion reaction was stopped 
by phenol/chloroform extraction, followed by ethanol precipitation. The linearized 
DNA was resuspended in 20 μl water. 1 μg of linearized DNA was used to synthesize 
DIG-RNA probe. The reaction was performed at 37℃ for overnight in a total volume 
of 20 μl containing 4 μl of 5× transcription buffer (Stratagene, USA), 2 μl of 
DIG-NTP mix (10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM UTP, and 3.5 mM 
DIG-UTP (Boehinger, Germany), 1 μl of RNAse inhibitor (40 U/μl) (Promega, USA) 
and 1 μl of T7 RNA polymerase (50 U/μl) (Promega, USA). Following the reaction, 2 
μl of RNAse free DNAseⅠ was used to digest the DNA template at 37℃ for 15 min. 
The digestion was stopped by adding 1 μl of 0.5 M EDTA (pH8.0). 2.5 μl of 4 M LiCl 
and 75 μl of cold 100% ethanol was added to precipitate the RNA. After washing with 
70% ethanol, the RNA probe was dissolved in 50~100 μl of DEPC treated water. 
 
2.7.2 Preparation of staged zebrafish embryos 
 
All zebrafish embryos used in this project were staged according to the Kimmer et al. 
(1995) and indicated as hours post fertilization (hpf) at 28.5℃. Staged embryos were 
fixed in freshly prepared 4% paraformadehyde (PFA) /PBS for 12 to 24 hours at room 
Materials and methods 
47 
 
temperature (or 4 ℃  overnight). Embryos before 16 hpf were fixed without 
dechorionization and the chorion was removed afterwards. Embryos older than 16 hpf 
were de-chorionated before fixation. Older embryos with tails were hibernated on ice 
for 5 min before fixation to prevent the curling of the tails. After fixation, the embyos 
were washed in PBST (0.1% Tween 20 in PBS) twice for one min each, followed by 
four times for 15 min on a nutator (CLAY ADAMS brand, Becton Dockinson, USA) 
at room temperature. After changing PBST to methanol, the embryos were kept in -20℃ 
for several months. Before they were used for in situ hybridization, the embryos were 
re-hydrated in PBS in two or three times by changing half volume of solution each 
time. 
 
2.7.3 Proteinase K treatment 
 
Embryos older than 24 hpf were treated with 10 μg/ml of proteinase K in PBST at 
room temperature. The time of treatment depended upon the age of embryos and the 
specific activity of proteinase K, which varied from batch to batch. In most cases, the 
following time table was adopted. 
Stage of embryos  Reaction time 
24-32 hpf 5-6 min 
32-50 hpf 10-20 min 
50-72 hpf 20-45 min 
72 hpf or older 45-75 min 
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To stop the proteinase K reaction, the proteinase K solution was removed completely, 
and the embryos were re-fixed in 4% PFA/PBS for 20 min at room temperature. 





Prehybridization was performed by changing half volume of washing solution with 
hybridization buffer and incubated at room temperature for one hour. This solution 
was removed and replaced with hybridization buffer and embryos were incubated at 




100 ng of DIG-labeled probe was diluted in 100 μl of hybridization buffer and 
denatured at 80℃ for 5 min followed by 5 min of ice bath. Embryos of different 
stages were selected and mixed together. The original buffer was removed completely 
and the probe was added in. Hybridization was performed at 70℃ in a circulating 
water bath overnight with shaking. 
 
2.7.6 Post-hybridization washing 
The probe was removed and replaced with pre-warmed 5×SSC. The embryos were 
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washed in 5 min each with PBS 
 
2.7.7 Incubation with antibody 
2.7.7.1 Preparation of preabsorbed DIG-AP antibody 
 
Commercial DIG-AP antibody (Boehringer, Germany) should be preincubated with 
biological tissues, preferably of the same region as the sample that later will be used 
for detection of signals, to decrease the staining background and increase 
signal-to-noise ratio. In this project, anti-DIG-AP was diluted to 1:500 in PBS/10% 
FBS and incubated with 50 zebrafish embryos of any stage on a nutator at room 
temperature for several hours. After that, this antibody solution was transferred to a 
new tube and diluted to 1:5000 with PBS/10% FBS. The preabsorbed antibody was 
stored at 4℃ and used repeatedly. 
 
2.7.7.2 Incubation with preabsorbed anti-DIG-AP antibody 
 
The embryos after hybridization and post-hybridization washes were incubated in 
PBS/10% FBS for 2 hours at room temperature to block non-specific binding sites for 
antibody. After removing the blocking solution, the embryos were incubated with 
preabsorbed anti-DIG-AP antibody at 4℃ overnight. 
 
 





Embryos were washed in PBST twice for one min each, and 4 times for 45 min each 
on a nutator at room temperature followed by washing in buffer 9.5 ( 0.1 M Tris-HCl, 
pH9.5; 50 mM MgCl2 , 10 mM NaCl and 0.1% Tween 20) once for 30 seconds and 
twice for 10 min each. 4.5 μl of NBT (nitro blue tetrazolium, Boeringer, Germany) 
(50 mg/ml in 70% dimethyl formamide) and 3.5 μl of BCIP (5-bromo 4-chloro 
3-indolil phosphate, Boeringer, Germany) (50 mg/ml in H2O) was added into 1 ml of 
buffer 9.5 with embryos and mixed thoroughly. Embryos were kept in dark at room 
temperature for several hours, and the progress of staining was monitored from time 
to time under a LEICA MZ12 microscope (Leica, Germany). To stop the reaction, 
staining solution was removed and the embryos were washed in PBS twice for 10 min 
each. Embryos were preserved in 4% PFA/PBS at 4℃. 
 
2.7.9 Mounting and photography 
 
Selected embryos were washed with PBS twice for 10 min each and transferred to 50% 
glycerol/PBS, equilibrated at room temperature for two hours. For whole mount, a 
single chamber was made by placing stacks of 2-3 small cover glasses on both sides 
of a 25.4×76.2 mm microscope slide. Small cover slips in the stacks will be fixed in 
one hour after placing a drop of Permount between them. Selected embryo was 
transferred to the chamber in a small drop of 50% glycerol/PBS and oriented by a 
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needle. A 22×24 mm cover slip with a small drop of the same buffer was 
superimposed onto the embryo. The orientation of the embryo can be adjusted by 
gently moving the cover glass. 
 
For flat specimen, the yolk of selected embryo was carefully removed by needles. The 
embryo without yolk was then placed onto a slide with a small drop of 50% 
glycerol/PBS and adjusted to a proper orientation by removing excess of liquid and by 
needles. A small fragment of cover slip (as small as possible) was covered onto the 
embryo. Care was taken to avoid bubbles and a drop of 50% glycerol/PBS was added 
to fill the space under the cover slip. This specimen was sealed with nail polish along 
the edge of the cover glass to prevent it from drying. 
 
Photos were taken using a camera mounted to an Olympus AX-70 microscope 
(Olympus, Japan). The film used was Kodak Gold 400 ASA. Digital photos of section 
embryos were taken on a Zeiss microscope (Zeiss Axiovert 25) installed with a CCD 
digital camera. 
 
2.8  Quantitive real-time PCR  
 
First-strand cDNA was synthesized using SuperScript
TM ⅡRT (Invitrogen) and 
real-time PCR was conducted using LightCycler DNA amplification kit SYBR Green
Ⅰ(Roche Applied Science) according to the manufacturer’s instruction manual with 
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minor modifications. Briefly, 2 μg of total RNA was mixed with 2 μl of Oligo (dT) 
(0.5 μg/ml), 2 μl of dNTP (10 mM each) and sterile water to make up 20 μl of total 
volume. The mixture was heated at 65℃ for 5 min and quick chilled on ice. Then 8 
μl of 5×First-Strand Buffer, 4 μl of 0.1 M DTT, and 1 μl of RNaseOUT (Invitrogen) 
(40 units/μl) were added into the previous mixture and incubated at 42℃ for 50 min. 
To inactivate the reaction, the previous reaction product was heated at 70℃ for 15 
min. The synthesized first-strand cDNA was diluted at least for 10 times before it 
could be used as template in real-time PCR. Prior to quantification, the optimal 
concentrations of template, primers, and magnesium were determined. Each real time 
PCR reaction mix was prepared to final volume of 10 μl, containing 0.2 of Tap DNA 
polymerase, 0.5 μl of each of 10 μM primer, 1.2 μl of 25 mM Mg2+, 1.8 μl of 5×
reaction mixture (dNTP mix and SYBR Green I dye), and 60 ng of total RNA in a 
LightCycler capillary tube. PCR was performed for 45 cycles with denatureation at 
95℃, annealing at 57℃ (variable), and extension at 72℃, followed by a melting 
curve analysis as described in the manufacturer’s protocol. Each run consisted of a set 
of 10-fold serial dilution of positive control RNA isolated from injected embryos for 
construction of a standard curve.  
 
2.9 Histological analysis 
2.9.1 Fixation 
 
Adult fish were anaesthetized in 0.1% phenoxyethanol and fins were cut for 
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genotyping to identify transgenic fish. The tail was removed by cutting from anus. 
Whole fish was dissected and the health status of fish was diagnosed based on the 
color, size and outline of fish trunk, skin, eyes, gill, and all the internal organs. If the 
tumor mass was bigger than 0.3 cm in diameter, 1/2-2/3 of the tumor was cut and 
stored at -80℃ for future assays. Information including tank location, age of fish, 
gender and any abnormalities of fish was recorded. Bouin fixative (saturated picric 
acid: formalin: acetic acid, 10:5:1) was used to fix the whole fish for 5 days.  
 
2.9.2 Dehydration and infiltration 
 
The fixed fish was washed with 70% ethanol by changing ethanol twice each day in 
the following 4 days until yellow color faded. To dehydrate, the sample was processed 
in the following sequence: 70% ethanol, 1 hr; 90% ethanol, 2 hrs; 95% ethanol, 1 hr; 
100% ethanol, 2 hrs; 100% ethanol, 1 hr; 100% ethanol, 1 hr; 50% ethanol /50% 
Histoclear, 30 min; HistoclearⅠ,1.5 hrs; HistoclearⅡ, overnight; ParaffinⅠ, 2 hrs; 




Unused paraffin was melted in a 60℃ oven. Samples were transferred to the unused 
paraffin in a small mold for embedding. 
 





Sectioning (5 um in thickness) was performed using a microtome and sagittal sections 
were obtained for each fish. 9 sections were collected from each fish and three 
sections were assayed on each slide. The sections were then stained by Haematoxylin 




To remove paraffin, the slides were soaked in the following solutions: HistoclearⅠ, 
10 min; HistoclearⅡ, 10 min; 100% ethanol, 2 min. To rehydrate, the slides were 
incubated in the following sequence: 100% EtOH, 3 min; 90% EtOH, 3 min; 70% 
EtOH, 3 min; 50% EtOH, 3min; Milli-Q water, 5 min; Milli-Q water 5min. To stain 
the sections, the following steps were followed to soak the slides: Haematoxylin, 30 
min; Distilled water, 1min; Acid Alcohol (1% HCl or H2SO4 in absolute EtOH), few 
seconds; Distilled water, 1min; Running tap water, 3-4 min; Distilled water, 1min; 50% 
EtOH, 3 min; 70% EtOH, 3 min; 90% EtOH, 3 min; Eosin, 3 min; 90% EtOH, 3min; 
100% EtOH, 3 min; 100% EtOH, 3 min; HistoclearⅠ, 5 min. The stained slides were 
kept in HistoclearⅡ until they were mounted in DePeX mounting medium (BDH 
Laboratory Supplies, Poole, U.K.). 
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2.10  E2 treatment of Tg(mvtg1:mMyc-GFP) zebrafish lines. 
 
To test the function of mvtg1 promoter in transgenic zebrafish, E2 treatment was 
carried out on Tg(mvtg1:mMyc-GFP) zebrafish lines. 5 mature adult male fish were 
treated with E2 (5 μg/L) for 72 hrs, with changing water every 24 hrs. After the 
treatment, these 5 fish were dissected together with 2 mature adult male fish and 3 
mature adult female fish, and RNAs of five different tissues (liver, intestine, skin, 
muscle and gonad) were extracted from each fish. RNA samples were then 
reverse-transcribed to cDNA, which were used as PCR templates after 10-fold 
dilution. 
 
2.11  Oncogene transgenic lines used in the present project. 
 
The oncogene transgenic zebrafish lines used in the present project and their 
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Table 1. Summary information on transgenic lines characterized in the present 
study. 
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In these transgenic zebrafish lines, tet-on inducible system is utilized and mouse cMyc 
(mMyc) oncogene is driven by liver-specific zebrafish promoter lfabp (liver fatty acid 
binding protein). Liver fatty acid binding protein is a 40-kDa protein, and is thought 
to play an important role in the intracellular binding and trafficking of fatty acids in 
the liver (Gordon et al., 1985). Three isoforms have been found in zebrafish 
organs/tissues: brain, liver and intestines, which have the ability to bind and facilitate 
uptake of fatty acids and are designated as bfabp, lfabp and ifabp respectively. The 
zebrafish ifabp is uniformly expressed in the intestine. The zebrafish bfabp is 
expressed in the periventricular gray zone of the optic tectum of the adult zebrafish 
brain. The lfabp is expressed exclusively in the liver of the adult zebrafish. The 
promoter region of zebrafish lfabp gene has been isolated and transgenic fish lines 
have been established by expressing GFP under the lfabp gene promoter. The 2.8-kb 
5’-flanking sequence of zebrafish L-FABP genewas sufficient to direct GFP 
expression specifically in liver (Her et al., 2003). The transgenic lines were generated 
by co-injection of the plfabp:rtTA;Tre:mMyc-GFP construct with pkrt4:RFP (krt4 
represents cytokeratin, i.e. a skin specific promoter) construct so that it is convenient 
to distinguish transgenic progeny from non-transgenic siblings based on whether they 
have the red fluorescent color in the skin. Two stable transgenic lines, line 32 and line 
129, were characterized. From the preliminary results by in situ hybridization, the 
mMyc transgene is expressed specifically in the liver in both lines (data not shown). In 
the present study, line 32 was used for the further characterization. 
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3.1 Test of the functionality of the Tet-on system 
 
To test the functionality of the Tet-on system in Tg(lfabp:rtTA;Tre:mMyc-GFP) lines, 
Dox treatment was carried out on fry fish. Firstly, the fry fish were separated into two 
groups at 2 dpf, based on whether they have the red fluorescent color in the skin. Then 
the fish were treated with Dox of three different concentrations: 10 μg/ml, 30 μg/ml 
and 60 μg/ml from 4 dpf to 6 dpf (i.e. 48 hrs treatment), and RNAs of these 6 dpf fish 
were extracted at the end of the 2-day Dox treatment. After this treatment, in another 
group, Dox was removed and the rest of these Dox treated fish were kept in fresh 
water for 24 hrs. Thus, the RNAs of these remaining recovered fish were sampled at 7 
dpf. All these collected RNAs were applied to RT-PCR and the result is shown in 
Fig.5 A. Primers to detect mMyc cDNA were used, and we observed that, after 48 hrs 
treatment, the brands of 10 μg/ml, 30 μg/ml and 60 μg/ml groups become brighter and 
stronger, showing a dosage effect; In the recovering group, at 24 hrs after removing 
Dox, we observed that the mMyc expression in higher concentration group always last 
longer, further confirming the dosage effect, i.e. when the concentration of Dox 
increased, the mMyc expression level became stronger and the activation time also 
last longer.  
 
To investigate the spacial expression of mMyc, in situ hybridization assay was carried 
out for 6 dpf transgenic progeny after Dox treatment, and we found that mMyc was 
specifically expressed in the liver (Fig. 5 B), suggesting that this Dox-inducible 
Characterization of Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic lines 
60 
 





























Figure 5. mMyc expresses in Tg(lfabp:rtTA;Tre:mMyc-GFP) after Dox treatment. 
(A) RT-PCR result. 27 amplification cycles were used for all the samples. (This 
picture is adapted from Huiqing Zhan) (B) in situ hybridization analyses for transgene 
mMyc expression in Tg(lfabp:rtTA;Tre:mMyc-GFP) embryos. The specific expression 
of mMyc in liver was detected at 6dpf using anti-sense probe for mMyc. The liver 
positions are indicated by arrows. 
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3.2 Tumorigenesis after Dox treatment. 
 
To test the tumorigenesis of mMyc in transgenic zebrafish liver, long term Dox 
treatment was carried out using 10 μg/ml, 30 μg/ml and 60 μg/ml Dox. All the fish 
were treated from 21 dpf. In the 10 μg/ml group, no abnormality was observed during 
a 2 months Dox treatment. In 30 μg/ml and 60 μg/ml groups, 100% transgenic 
progenies showed enlarged belly and swimming difficulty at 34 dpf (i.e. 13 days after 
Dox treatment) (Fig. 6). Fig. 6 A is the side view of non-transgenic fish and abnormal 
transgenic fish at 45 dpf (24 days of Dox treatment), and we observed that the 
transgenic progeny had much bigger belly than those of the non-transgenic control. 
After the fish were dissected, we could see the obvious difference between 
non-transgenic (Fig. 6 B) and transgenic fish (Fig. 6 C) livers (outlined by black 
broken lines). The liver of transgenic fish was greatly enlarged in comparison with the 
normal liver. 9 out of 41 fish in the 60 μg/ml group died during 41-43 dpf (i.e. 20-22 
days post-treatment) while none of the fish died in the 30 μg/ml group. Additionally, 
in the 30 μg/ml group, most fish recovered from this abnormal phenotype at around 
50 dpf (i.e. 30 days post treatment). These data suggest that fish in 60 μg/ml group 


















Figure 6. Abnormal phenotype observed in Tg(lfabp:rtTA;Tre:mMyc-GFP) 
progeny after Dox treatment using 60 μg/ml concentration. (A) Side view of 
normal non-transgenic fish and abnormal transgenic fish. (B) Enlarged view of 
dissected non-transgenic fish after Dox treatment. (C) Enlarged view of dissected 
abnormal transgenic fish after Dox treatment. The livers in (B) and (C) are 
outlined by black broken lines.  
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3.2.1 Several putative Myc downstream genes showed obvious up-regulation. 
 
To investigate whether Myc gene pathways were activated in the fish with abnormal 
phenotypes, expression of selected c-Myc downstream genes was determined by 
semi-quantitive RT-PCR. 2 transgenic progenies from 60 μg/ml Dox group were 
randomly chosen (labeled S1 and S2), together with 2 internal negative controls: 1) 
Transgenic progeny without Dox treatment (labeled C1); 2) Non-transgenic sibling 
with Dox treatment (labeled C2). As shown in Fig. 7, both transgenic samples showed 
very strong mMyc expression after treatment by 60 μg/ml Dox, while no mMyc 
expression can be detected in both internal negative controls. Eight putative Myc 
downstream genes, which have been reported to be Myc up-regulated, were examined 
to investigate the activation of Myc gene pathways. These eight genes are: cad, cdc2, 
cyclinA1, cyclinD1, cyclinE, eif4e1a, ldha, and odc, and their functions are involve in 
Cell cycle (cyclinD1, cyclinA1, cyclinE , cdc2), DNA metabolism (cad), energy 
metabolism (ldha, odc), and protein synthesis (eif4e1a), (For a detailed description of 
these genes and other Myc target genes, please refer to cMyc target gene database, 
http://www.myccancergene.org). By comparison of the expression level of these 
genes in transgenic group (S1, S2) and control group (C1, C2), we observed that most 
of these genes, such as cad, cdc2, cyclinA1, cyclinD1, cyclinE, and odc, show 









Figure 7. Examination of several putative c-myc downstream genes by 
semi-quantitive RT-PCR. Eight downstream genes of Myc were selected from 
reported up-regulated Myc downstream genes. Lane S1 & S2: RFP+, Dox 60 μg/ml, 35 
dpf fish liver sample 1 &2; Lane C1: RFP+, Dox-, 35 dpf fish liver sample as control 
1; Lane C2: RFP-, Dox 60 μg/ml, 35 dpf fish liver sample as control 2.  Transgenic 
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3.2.2 The abnormality was diagnosed by histopathology as neoplasm. 
 
Several dying fish from 60 μg/ml Dox treatment group (around 20 days post treatment) 
were fixed in Bouin fixative for histopathological analysis. The result is shown in Fig. 
8. Fig. 8 A is transgenic fish without Dox treatment as control, and Fig. 8 B is 
non-transgenic sibling with 60 μg/ml Dox treatment as another control, both of which 
show normal liver morphology. Fig. 8 C-D are two transgenic fish randomly selected 
from several dying fish in the 60 μg/ml Dox treatment group. The slides were 
diagnosed as hepatocellular hyperplasia and hepatocellular adenoma with the help of 
































Figure 8. Histopathological analysis of abnormal transgenic progeny of 
Tg(lfabp:rtTA;Tre:mMyc-GFP) lines. (A) Transgenic progeny without Dox 
treatment as a control. (B) Non-transgenic sibling with 60 μg/ml Dox treatment 
as another control. (C) Transgenic progeny No.1 with 60 μg/ml Dox treatment. 
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3.3   Discussion 
 
Since Myc was identified as the human homologue of a retroviral oncogene just 26 
years ago, intensive studies on Myc have been carried out and tremendous advances 
have been achieved. At the time when research on Myc began, the genetic basis of 
cancer was largely unknown. Studies on Myc have not only helped us to understand 
Myc regulation and function in tumorigenesis, but also have an impact on numerous 
biological disciplines, including our understanding of molecular oncogenesis in 
general. The present project represents the first attempt to investigate the function of 
mouse c-Myc in the liver of transgenic zebrafish. This transgenic strategy is based on 
the demonstrated role of MYC in the tumorigenesis in human liver cancers, as well as 
its ability to induce liver tumors when aberrantly expressed in transgenic mice.  
Myc-induced T cell leukemia is the first study of mouse c-Myc in transgenic zebrafish 
(Langenau et al., 2003). In this study, mMyc is expressed specifically in lymphoid 
cells under the control of zebrafish Rag2 promoter (Jessen et al., 2001). In our studies, 
the same mMyc oncogene was used, and also EGFP was fused to mMyc as a reporter 
gene; however, in the study of Langenau et al. (2003), EGFP was fused to the 
N-terminal of mMyc; while in our case, EGFP was fused to the C-terminal of mMyc. 
The original idea to put EGFP at the C-terminal of mMyc is that, firstly, although the 
functionality of EGFP fused to the C-terminal of mMyc has not been reported, when 
the EGFP was observed, we are more assured that the transgene mMyc has been fully 
transcribed. Unfortunately, the EGFP expression in our transgenic lines was not 
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successful, indicating that fusing EGFP in the C-terminal of mMyc may affect its 
fluorescence. 
 
The mean latencies of tumor development in Tg(zRag2:mMyc) and 
Tg(zRag2:EGFP-mMyc) fish were 44 and 52 days (ranging 30 to 131 days), 
respectively (Langenau et al., 2003); in our study, liver neoplasm was onset after 20 
days of Dox treatment, thus a longer time induction may be needed for the fully 
development of liver tumor. 
 
In mouse models, it is reported that co-expression of TGF-α accelerates HCC 
development and increase HCC incidence in cMyc/TGF-α double transgenic line 
(Murakami et al., 1993; Santoni-Rugiu et al., 1996); while co-expression Bcl-2 gene 
inhibits the emergence of liver tumors in cMyc/Blc-2 double transgenic mice. Thus, in 
future, it will be interesting to generate transgenic zebrafish lines with TGF-α or Bcl-2 
gene to further investigate the role of mMyc in our transgenic zebrafish lines. 
 
As described in the result sections, during the long-term Dox treatment, the phenotype 
of abnormal transgenic zebrafish from 30 μg/ml group became less severe, indicating 
that they may have slowly recovered from 20 to 30 dpt (days post treatment). There 
are also similar reports in human liver cancer cells. Catherine et al., (2004) have 
reported that inactivation of the MYC oncogene is sufficient to induce sustained 
regression of invasive liver caners and they proposed that oncogene inactivation may 
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reverse tumorigenesis in most cancers. Although in our case, the mMyc expression in 
the 30μg/ml group was only at a low level rather than completely inactivated, it still 
provide valuable indication for the future studies.  
 
In addition, several different starting time point of the Dox treatment on adult fish (e.g. 
3 months old, 60 dpf and 30 dpf are proposed to carry out as a future direction, in 
order to verify whether it would be easier to induce tumor when the fish is younger, 
and whether there is some tumor-resistant mechanism when fish becomes mature.  
In this preliminary experiment, tumor incidence and the number of fish which have 
tumors over the total number of dead fish have not been calculated. As discribed 
previously, after Dox induction, all the transgenic fish with mMyc oncogene 
developed a big belly, which is regarded as the early stage of tumor development. 
Therefore, further work would be needed to get a clear figure regarding tumor 
incidence. 
 
In this study, we have demonstrated that Tet-on system is functional in 
Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic lines under the control of liver-specific 
promoter lfabp, and induced expression of mMyc in liver of 
Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic lines leads to hepatocellular hyperplasia in 
the liver after 20 days Dox treatment. Therefore, it could be an invaluable model to 
study the mechanism of liver cancer development. 
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4.1   mvtg1 gene promoter is E2-inducible in Tg(mvtg1:mMyc-GFP) 
zebrafish  
 
In Tg(mvtg1:mMyc-GFP) transgenic lines, mouse c-myc gene (mMyc) is fused with 
enhanced green fluorescent protein gene (egfp) as a reporter gene, and their 
expression is under the control of medaka vitellogenin1 (mvtg1) gene promoter.  
 
Vitellogenins (vtg) are precursors of egg yolk proteins and are normally synthesized 
only in the liver of adult females in oviparous vertebrates under the control of the 
female hormone. vtg mRNA expression can also be induced in male fish by estrogen. 
mvtg1 gene promoter has been isolated and tested in medaka. By expressing GFP 
under mvtg1 gene promoter and observe the GFP expression, Zeng et al. concluded 
that mvtg1 is exclusively expressed in the liver of the mature adult female. Male and 
juvenile fish, which do not express mvtg1, could be induced to express mvtg1 in the 
liver after exposure to 17-β-estradiol (E2) (Zeng et al., 2005). 
 
The function of mvtg1 promoter has not yet been tested in zebrafish. In order to test 
whether the mvtg1 promoter functions in zebrafish, the expression patterns of 
zebrafish vitellogenin1 (zvtg1) and mMyc were examined by semi-quantitive RT-PCR. 
RNA samples of 5 different tissues (liver, intestine, skin, muscle and gonad) were 
extracted from individual fish of the three groups: mature adult male fish (2 
replicates), mature adult female fish (3 replicates) and E2 treated mature adult male 
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fish (5 replicates) and reverse-transcribed to DNA, which were used as PCR templates 
after 10-fold dilution. β-actin was used as an internal control for equal loading and the 
result is shown in Fig. 9. It is interesting to note that zebrafish vtg1 mRNA was 
mainly expressed in female liver and intestine, as well as in all the 5 tissues of E2 
treated male (Fig. 9). It is known that mvtg1 gene promoter can be activated by E2 in 
























Figure 9. Tissue distribution of zvtg1 and mMyc mRNAs in male, female and E2 
treated male fish of Tg(mvtg1:mMyc-GFP). (A) Untreated group which contains 2 
male replicates and 3 female replicates (labled ―♂‖ and ―♀‖ respectively at the 
bottom). β-actin was used as an internal control for viewing equal loading of RNA 
samples. (B) E2-treated group which contains 5 E2 treated male replicates. β-actin in 
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reproducibly expressed in female and E2-treated male fish liver. While the induction 
of mvtg1 gene promoter by E2 in the liver of Tg(mvtg1:mMyc-GFP) was quite 
successful, there are a lot of individual variation in induction in other tissues (Fig. 9) 
.  
4.2 Leaky expression of mMyc at early stage. 
 
Since Tg(mvtg1:mMyc-GFP) was generated by co-injection with pkrt4:RFP, and thus 
the transgenic progeny could be recognized by red fluorescent color in skin. 
Transgenic progeny (RFP+) and non-transgenic siblings (RFP-) were separated into 
two groups at 2 dpf, and then treated separately with E2 (5 μg/L) at 5 dpf for 42 hours. 
At 7 dpf, some of the fish were used for RNA extraction and the rest were fixed in 4% 
PFA-PBS for in situ hybridization and RT-PCR assays. 
 
The results of two-step RT-PCR and in situ hybridization are shown in Fig. 10. As 
shown in Fig. 10 A, at 7 dpf, the zvtg1 expression level was quite low, while the 
mMyc expression was more prominent and could be detected in both E2-treated and 
non-E2-treated RFP+ fish, indicating that there was leaky expression of mMyc at early 
stage. By in situ hybridization, we noticed that liver and intestine are stained by mMyc 
antisense probe in both E2-treated and untreated transgenic fry, indicating that the 











Figure 10. Expression of mMyc in Tg(mvtg1:mMyc-GFP) transgenic lines at early 
stage. (A) mMyc mRNA expression was detected by RT-PCR in 7 dpf fish. Lanes 
labeled E2+,RFP+ and E2-, RFP+ represent E2-treated transgenic fish and untreated 
non-transgenic zebrafish. β-actin was used as an internal control for viewing equal 
loading of RNA samples. (B)—(J) in situ hybridization result staining by mMyc 
anti-sense probe. (B)—(D) lateral view; (E)—(G) ventral view; (H)—(J) enlarged 
view of the staining part in (E)—(G). The gut positions were indicated by arrows. 
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4.3   The expression level of mMyc is much lower than zvtg1 in zebrafish 
liver. 
To further investigate the function of mvtg1 gene promoter in zebrafish liver, we 
aimed to test the efficiency of this promoter, by comparison of expression level of 
mMyc and zvtg1 mRNA using real-time RT-PCR for quantification of zvtg1 and mvtg1 
mRNAs. 5 replicates of liver RNA samples from adult male fish, adult female fish, 
and E2-treated male fish were extracted and converted to cDNAs by 
reverse-transcription. Plasmids with known concentration containing zvtg1 (plasmid 
A248, a cDNA clone of zvtg1 from the previous work of our lab) (Gong et al., 1997) 
and mMyc (plasmid plfabp:mMyc-GFP) gene respectively were used to generate 
standard curve, by which the absolute concentrations of zvtg1 and mMyc of our 
samples were calculated. The results are shown in Fig. 11. An example of 
amplification curves is shown in Fig. 11 A. A typical standard curve for zvtg1 is show 





 copies. Melting curve analysis was performed to determine the 
characteristic melting temperature of the target DNA and to identify or genotype 
products based on their melting temperature (Fig.11 C). 5 replicates were used for 
each group: untreated male fish, untreated female fish and treated male fish, and 
average concentrations were calculated (Fig.11 D). The result shows that the 
expression level of zvtg1 is 10
3
 higher than that of mMyc in untreated female fish and 
10
4 
higher in E2-treated male fish, suggesting that the efficiency of promoter mvtg1 is 
relatively low in transgenic zebrafish.  








 Untreated male  Untreated female  Treated male  
Zvtg1  Not Detectable  8.51E+08  2.58E+08  
mMyc 
 
Not Detectable  2.53E+04  6.25E+04  
Figure 11. Quantification of zvtg1 and mMyc mRNAs using real-time RT-PCR. (A) 
An example of amplification curves. (B) An example of standard curve generated by 





 copies was used for 35 cycles amplification. The amplification plot (left) and 
standard curve (right) were downloaded directly from the computer screen when data 
were analyzed by LightCycler 480 software. The standard curve was generated by 
plotting the copy numbers of the target gene (copy number: 10
5–109) against the 
respective crossing points (the threshold cycle value when the fluorescent signal rises 
above background level) for each dilution. (C) An example of melting curve assay. (D) 
The absolute concentrations (copy number per microgram of total RNA) of zvtg1 and 
mMyc mRNA 
B 
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4.4   Putative mMyc downstream genes are activated with mMyc 
expression  
 
Since the liver is the only tissue in which mMyc shows strongest and consistent 
induction, we would like to investigate whether it is possible to generate a zebrafish 
liver cancer model by expressing mMyc under the control of mvtg1 gene promoter. 
The mMyc was constitutively expressed in liver of mature adult female fish; however, 
no abnormality was observed in adult female fish. There was no abnormality observed 
as well in E2-treated male and female fish during the 72 hrs short-term treatment. 
Based on the result of quantitive real-time RT-PCR, we suspect that, although mMyc 
is constitutively expressed in the transgenic progeny, the expression level might not 
be high enough for tumorigenesis. To make further validation of this assumption, we 
tested some downstream genes of Myc which are reported to be up-regulated when 
mMyc is activated be real-time PCR (Fig. 12). 4 genes were tested here: cad, cdc2, 
ldha and odc, and except for the cad gene in untreated female group, all these genes 
















Figure 12. Expression log fold change of 4 putative downstream genes of mMyc. 
All these 4 genes are reported to be up-regulated in Myc gene pathways. Grey bars 
represent log2 fold change of each group. Except for the cad in untreated female 
group, all these genes in untreated female group and E2 treated male group show 
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4.5   Discussion 
4.5.1 The mvtg1 gene promoter is inducible by E2 in transgenic zebrafish liver.  
 
The function of mvtg1 gene promoter has been tested in Tg(mvtg1:GFP) transgenic 
medaka in the previous work of our lab (Zeng et al., 2005). We found that mvtg1 
promoter functions as a faithful estrogen-inducible promoter in medaka fish, and 
transgenic GFP in Tg(mvtg1:GFP) transgenic medaka is faithfully expressed in 
female livers and in estrogen-treated male livers, perfectly mimicking the expression 
pattern of the endogenous mvtg1 (Zeng et al., 2005). 
 
In this study, one of the main purposes was to test whether it functioned in the same 
way in transgenic zebrafish, in order to develop a new inducible, liver-specific 
expression system to help us generate zebrafish liver cancer model. From the 
experiment results, we observed that the oncogene mMyc, under the control of mvtg1 
promoter, had showed the same expression pattern of the endogenous zvtg1 in 
zebrafish liver. However, in other tissues (i.e. intestine, skin, muscle and gonad) of 
E2-treated fish, there were a lot of variation in mMyc expression while the 
endogenous zebrafish vtg1 was induced to express in all these tissues reproducibly, as 
reported previously (Wang et al., 2005). Furthermore, there was a high level of leaky 
mMyc expression in early stage, but the leaky expression becomes very low in adult 
stage. Therefore, we may summarize the activity of mvtg1 gene promoter in zebrafish 
as following: (1) mvtg1 gene promoter can drive the transgene to express reliably in 
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the liver of mature adult female fish and E2 treated male fish, but weakly and 
inconsistently in other tissues. (2) The gene under the mvtg1 promoter might have 
high leaky expression at early stage of zebrafish and the leaky expression at adult 
stage is very low.  
 
4.5.2 The expression level of mMyc under mvtg1 promoter is too low for 
tumorigenesis. 
 
Expression of oncogene mMyc can be constitutively activated in adult female fish 
liver; however, we have not observed any abnormality in all the generations of the 
transgenic female fish. To confirm whether Myc pathway is enhanced in the 
transgenic line, we examined four downstream genes which had been reported to be 
upregulated when Myc is activated. There four genes are cad, cdc2, ldha and odc. All 
four genes showed up-regulation, suggesting that the Myc gene pathway has been 
activated. To understand why the constitutive mMyc expression failed to cause tumor 
phenotype in the transgenic fish, the absolute mMyc RNA concentration was 
examined by using real-time PCR. The copy number of mMyc mRNA in 1 μg of total 
liver RNA was estimated 2.53×104 in female fish and 6.25×104 in E2 treated male 
fish. However, the copy number of vtg1 mRNA in 1 μg of total liver RNA was 8.51×
10
8
 in female fish and 2.58×108 in E2 treated male fish. A comparison of mMyc copy 
number between Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic lines and 
Tg(mvtg1:mMyc-GFP) transgenic lines will be investigated in the future studies. At 
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this stage, we propose that the mMyc might be expressed at only a low level in 
Tg(mvtg1:mMyc-GFP) transgenic line, which was not sufficient to induce tumor up to 
1.5 years of age. 
 
4.5.3 Comparison of study on Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic lines 
and Tg(mvtg1:mMyc-GFP) transgenic lines 
 
In this study, two inducible mouse cMyc transgenic lines were characterized, 
Tg(mvtg1:mMyc-GFP) and Tg(lfabp:rtTA;Tre:mMyc-GFP), both of which aim to 
generate a zebrafish liver cancer model. In comparison of these two lines, we find 
several clues in terms of the function of mMyc in zebrafish liver tumorigenesis. Firstly, 
in both lines, GFP could not be observed while mMyc mRNA expression was detected. 
This is probably because the mMyc-GFP fusion protein may affect the structure of 
GFP proteins to emit GFP fluorescent properly. Although GFP has been reported to 
have proper function when fused at the C-terminal of other genes, we suggested that 
GFP is better to be fused with the N-terminal of mMyc to have GFP flurescence as 
reported previously (Langenau et al., 2003). Secondly, Tg(lfabp:mMyc-GFP) 
constitutive expression lines have been also developed and investigated in our lab 
(unpublished), and there was no increased tumor incidence observed in all generations. 
Since fish in Tg(lfabp:rtTA;Tre:mMyc-GFP) develop neoplasm rapidly after the 
induction of mMyc while there was no abnormality observed in Tg(mvtg1:mMyc-GFP) 
and Tg(lfabp:mMyc-GFP), Tet-on inducible system is demonstrated as a more 
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effective expression system in transgenic zebrafish to generate tumors. Further studies 
such as comparison of mMyc transcript copy number between 
Tg(lfabp:rtTA;Tre:mMyc-GFP) and Tg(mvtg1:mMyc-GFP) will be necessary to 
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5.1 Expression of Xmrk in Tg (lfabp:Xmrk) transgenic lines 
 
In these transgenic lines, oncogene Xmrk is under the control of liver specific 
promoter lfabp. In development of these transgenic lines, construct plfabp:Xmrk is 
co-injected with pkrt4:RFP, thus, we can distinguish transgenic offsprings based on 
GFP expression in the skin. There are two stable Tg(lfabp:Xmrk) transgenic lines to be 
characterized, named line 21 and line 40 respectively. To investigate the expression of 
Xmrk in these lines at mRNA level, one-step reverse transcription PCR and whole 
mount in situ hybridization were performed on zebrafish larvae. The represented 
RT-PCR result is shown in Fig. 13 A. Lanes labeled M,1,2,3,4 and 5 represent marker, 
line 21 GFP+, line 21 GFP-, line 40 GFP+, line 40 GFP- and negative control 
(non-transgenic wild type zebrafish) respectively, and β-actin was used as an internal 
control (lower picture). These RT-PCR data show that the expression of Xmrk can 
only be detected in GFP positive fish as anticipated. 
 
The spacial expression pattern of Xmrk was determined by whole mount in situ 
hybridization, as shown in Fig. 13 B-F. Xmrk was specifically expressed in the liver of 
GFP positive fish (indicated by arrows). All these results show the success of 
generating stable transgenic zebrafish lines with Xmrk mRNA specifically expressed 
in the liver. 
 
 





Figure 13. Expression of Xmrk mRNA in Tg (lfabp:Xmrk) transgenic lines.  
(A) One-step RT-PCR analyses of Xmrk expression in embryos of 5-6 dpf from 
Tg(lfabp:Xmrk) transgenic lines 21 and 40. Lane 1, line 21 GFP+; Lane 2, line 21 
GFP-; Lane 3, line 40 GFP+; Lane 4, line 40 GFP-; Lane 5, Genomic DNA of wild 
type zebrafish. The amplification cycles were 35 and 25 for Xmrk and β-actin 
respectively.  (B-E) In situ hybridization analyses for Xmrk expression in 
Tg(lfabp:Xmrk) transgenic embryos. The specific expression of Xmrk in liver was 
detected at 6 dpf using anti-sense probe for Xmrk. The liver positions are indicated by 
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As described above, both line 21 and 40 of stable Tg(lfabp:Xmrk) fish showed 
specific liver expression of Xmrk mRNA as determined by one-step RT-PCR and in 
situ hybridization. There was also no difference in phenotype observation between the 
two lines. For further characterization, we focused only on line 40.   
The expression level of Xmrk in line 40 was examined at different time points of early 
stage: 4 dpf, 7 dpf and 14 dpf (Fig. 14). The expression level of Xmrk was weaker at 4 
dpf (Fig. 14, labeled lane 1), and no obvious difference of Xmrk expression level 

























Figure 14. Expression level of Xmrk in Tg(lfabp:Xmrk) line 40. Lane 1—3: fish 
from 4, 7 & 14 dpf respectively. The expression level of Xmrk is weaker at 4 dpf, and 
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5.2   Xmrk does not affect the early stage development of         
Tg(lfabp:Xmrk) line 40  
 
In these Tg(lfabp:Xmrk) stable transgenic lines, oncogene Xmrk is constitutively 
expressed in zebrafish liver. However, no obvious abnormal phenotype was observed 
in all the generations from F1 to F4. We suspect that fish with strongest Xmrk 
expression might die at early stage and could not survive to adult fish, whereas all the 
survived adult fish were those with low Xmrk expression. To investigate whether 
oncogene Xmrk has influence on the survival of Tg(lfabp:Xmrk) fish, we examined 
the survival rate of Tg (lfabp:Xmrk) line 40 at early stage. Firstly, homozygous and 
heterozygous zebrafish were screened out by observing GFP expression in skin under 
a fluorescent microscope. After outcrossing with a wild type fish, the genotype of the 
parent fish was determined by Mendel’s law of segregation: i.e. if 100% of the 
progeny had GFP expression in the skin, the parent fish was homozygous; if 50% of 
the progeny had GFP expression in the skin, the parent fish was heterozygous. After 
genotype determination, heterozygous fish were picked up and incrossed. The reason 
to choose heterozygous progeny rather than homozygous fish is that we would like to 
generate non-transgenic siblings as a negative control, as well as homozygous and 
heterozygous transgenic progeny in the same batch for better matched control. After 
incross, the embryos were collected and separated according to GFP expression in the 
skin at 2 dpf. Then the fish were separated into 3 groups: GFP+, GFP- and 
GFP+/GFP- and grown in 3 different tanks in the first experiment (Tank 1, GFP+; 
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Tank 2, GFP-; Tank 3, GFP+/GFP-) and 5 different tanks in the second experiment 
(Tank 1&2, GFP+; Tank 3&4, GFP-; Tank 5, GFP+/GFP-). This experiment was 
repeated twice because the quality of the first batch of embyos was generally poor, 
with low survival rates in all groups. The results are shown in Figure 15.  
 
If the oncogene Xmrk has adverse effect on the early stages of these transgenic fish, 
we expected to see significant difference of the survival rate among GFP+, GFP-, and 
GFP+/GFP- group. However, in both batches of fish, there was no significant 
difference among the three groups: GFP-, GFP+ and GFP+/GFP-. In the GFP+/GFP- 
group of the first batch, the survived fish were observed under fluorescent microscope 
to identify their genotypes. Of 13 survived fish, 7 were GFP+ fish and 6 were GFP- 
fish, which again suggests that the oncogene Xmrk does not affect the early stages (1 


























Figure 15. Survival Rate of Tg (lfabp:Xmrk) line 40. (A--B) Survival rate of the 
first batch embryos. Panel (A) shows the number of survived fish in each tank at 6 
different time points and Panel (B) shows survival rate curve. (C--D) Survival rate the 
second batch embryos. Panel (C) shows the number of survived fish in each tank at 12 
different time points and Panel (D) shows survival rate curve. Average percentage of 
tank 1 and tank 2 was used for GFP+ group. Average percentage of tank 3 and tank4 
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5.3   Crossing of Tg (lfabp:Xmrk) line 40 with tp53M214K mutant transgenic 
line did not increase abnormal incidence at early stages. 
 
As described above, since no spontaneous tumorigenesis and abnormality was 
observed in Tg (lfabp:Xmrk) lines, we next crossed Tg (lfabp:Xmrk) line 40 with p53 
mutant transgenic line, which might increase the incidence of tumorigenesis and 
abnormality. TP53 is also known as p53 or tumor protein 53, and it regulates cell 
cycle in multicellular organisms and functions as a tumor suppressor. When DNA 
damage happens in cells, tp53 can cause a rest of cell cycle, allowing time for fix or 
lead to programmed cell death (i.e. apoptosis). When tp53 is mutated, cell will lack 
apoptosis and cell-cycle arrest in response to DNA damage, leading to accumulation 
of mutations to cause oncogenesis.  
 
More than 90% of identified tp53 mutations in human tumors are found in the 
DNA-binding domain of the protein
 
(Beroud et al., 2003; Olivier et al., 2002). The 
orthologous human codon for the zebrafish tp53
M214K
 mutation is mutated in 124 
different human tumors, while 8 of them exhibit the same amino acid change from a 
methionine to a lysine (Berghmans et al., 2005).  
 
The genotype of fish from tp53
M214K
 mutant transgenic line was identified by 
allele-specific PCR, using a single forward primer (5'-GAT AGC CTA GTG CGA 
GCA CAC TCT T-3') and two reverse primers to distinguish the mutant (5'-AGC TGC 
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ATG GGG GGG AA-3') and the wild-type (5'-AGC TGC ATG GGG GGG AT-3') 
alleles (Berghmans et al., 2005). Then heterozygous fish from Tg (lfabp:Xmrk) line 40 
were crossed with homozygous tp53
M214K
 mutant fish, so the genotype of the 
offsprings was 50% Xmrk (+/-)P53(+/-) and 50% Xmrk (-/-)P53(+/-). Two batches of 
embryos were collected for survival rate study. After the embryos were collected, the 
transgenic and non-transgenic fish were separated based on the GFP in the skin at 2 
dpf, and raised up in separate tanks until 1 month. The survival rate of both batches is 
shown in Fig. 16 (B &C). In both batches of fish, there was no significant difference 
between the transgenic (labeled GFP+) and non-transgenic (labeled GFP-) groups in 
survival rate. The result shows that heterozygous p53 mutant with heterozygous Xmrk 
oncogene did not show abnormality at early stages. 
 
The fish will be kept for a long term observation and in the future, these fish will also 
be incrossed to generate homozygous p53(-/-) fish with Xmrk oncongene to examine 



















Figure 16. Survival rate after crossing of Tg (lfabp:Xmrk) line 40 with tp53
M214K
 
mutant transgenic line at early stage. (A) The genotyping assay for the tp53
M214K
 
mutation used allele-specific PCR with a single forward primer (5'-GAT AGC CTA 
GTG CGA GCA CAC TCT T-3') and two reverse primers to detect the mutant 
(5'-AGC TGC ATG GGG GGG AA-3') and the wild-type (5'-AGC TGC ATG GGG 
GGG AT-3') alleles. (B) Number of survived fish in each tank and survival rate of the 
first batch of crossing. (C) Number of survived fish in each tank and survival rate of 




Characterization of Tg(lfabp:Xmrk) transgenic lines 
96 
 
5.4   Discussion 
 
The epidermal growth factor receptor (EGFR) variant Xmrk of the Mexican fish 
Xiphophorus is one of the first oncogenes described. The Xmrk gene is the duplicated 
version of the proto-oncogene egfrb. After certain repeated cross-breedings between 
the platy fish Xiphophorus maculatus and the swordtail Xiphophorus hellerii, Xmrk 
overexpression in pigment cells of the skin results in melanoma with a high malignant 
potential. The function of oncogene Xmrk has been usually studied in Xiphophorus 
and transgenic medaka fish, and researchers also tried to generate melanoma model in 
Xmrk-transgenic zebrafish, which contains the oncogene under the control of the 
pigment-cell specific nacre promoter, from the orthologue of MITF in humans 
(Werner et al., 2006).    
 
Our study is the first to investigate the function of oncogene Xmrk in zebrafish liver 
tumorigenesis. Since Xmrk is previously reported in melanoma, the first question 
considered is whether cell types will affect the function of Xmrk in tumorigenesis. In 
our previous studies, Xmrk was expressed under a ubiquitous promoter in zebrafish, 
and tumors in almost all tissues were observed (data not shown). Thus, we proceeded 
to express Xmrk specifically in the liver tissue; however, it failed to develop tumor in 
these Tg(lfabp:Xmrk) lines. Two possible reasons may contribute to this: (1) the 
tumors in all tissues in the previous study might be caused by metastases, which 
originated from epithelium cells. Therefore, certain cell types (e.g. skin cells) may be 
more susceptible to Xmrk while zebrafish liver cells (e.g. hepatocytes, endothelial 
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cells, lymphocytes, hepatic myofibroblasts and kupffer cells) were not susceptible 
enough for tumorigenesis; (2) since we have observed that in Tet-on Xmrk transgenic 
lines, Tg(lfabp:rtTA;Tre:Xmrk), transgenic progeny developed similar neoplasm as 
Tg(lfabp:rtTA;Tre:mMyc-GFP), indicating that Tet-on inducible system always has a 
better performance than constitutive expression system to generate liver tumor in both 
mMyc and Xmrk oncogene transgenic zebrafish lines. We noted that the different of 
Tet-on inducible system and constitutive expression system is that, oncogenes started 
expression at quite early stage (around 2 dpf) in constitutive expression system while 
oncogenes only started express when it is induced at later stage (after 21 dpf). Thus, 
we proposed that certain protective mechanisms might be present in early embryos by 
overexpression of these oncogenes at the early stages development.  
 
In the crossing of Tg(lfabp:Xmrk)×tp53 mutant lines, no increased tumor incidence 
was observed in the heterozygous F1 generation. However, homozygous genotype in 
tp53 gene or both Xmrk and tp53 gene might be necessary for tumorigenesis in the 
liver of this double transgenic line. Thus, further experiment to incross the F1 
heterozygous fish to generate F2 homozygous fish would be necessary to further 
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6.1 Major conclusions 
 
In this study, oncogene transgenic zebrafish in three different transgenic systems were 
characterized and compared, and the information is summarized in Table 2. The major 
conclusions from this present study include the following: 
 
1. The Tet-on system is functional in the stable Tg(lfabp:rtTA;Tre:mMyc-GFP) 
transgenic lines under the control of the liver-specific lfabp promoter, and the 
transgene mMyc indeed showed liver-specific induction by the inducer Dox. 
2. Induced expression of mouse c-Myc (mMyc) in liver of 
Tg(lfabp:rtTA;Tre:mMyc-GFP) transgenic lines leads to hepatocellular 
hyperplasia and hepatocellular adenoma in the liver after 20 days Dox treatment. 
3. Medaka vitellogenin1 (mvtg1) gene promoter is E2-inducible in the liver of male 
Tg(mvtg1:mMyc-GFP) transgenic zebrafish. 
4. At early stages of Tg(mvtg1:mMyc-GFP) transgenic line without E2 induction, 
transgene mMyc under mvtg1 promoter has leaky expression in liver and intestine, 
while mvtg1 promoter can control the expression of its driven gene in a 
E2-inducible manner quite strictly in the liver of adult fish. 
5. However, the mMyc was expressed at only a low level in Tg(mvtg1:mMyc-GFP) 
transgenic line, which may not be sufficient to induce tumors up to 1.5 years of 
age. 
6. Constitutive expression of oncogene Xmrk in the liver of Tg (lfabp:Xmrk) 
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transgenic line was successful, but there was no increased tumor incidence found 
up to 1.5 years of age. 
7. The survival rates at early stages were similar among Xmrk (+/-) &(+/+) and wild 
type fish; similar survival rates at early stages were also observed between p53(+/-) 
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Table 2. Summary of characterization of oncogene transgenic zebrafish lines in 
























GFP) line 32 
+ +   + 
Tg(lfabp:rtTA;Tre:mMyc-
GFP) line 129 
+ +   + 
Tg(mvtg1:mMyc-GFP) 
line 30 
+ +  + - 
Tg(lfabp:Xmrk)  
line 21 
+ +   - 
Tg(lfabp:Xmrk)  
line 40 
+ + √  - 
 
Note: 
1. Tg (lfabp:Xmrk) line 40 was used for the further analysis (i.e. survival rate study 
&crossing with p53 mutant line) of Tg(lfabp:Xmrk) transgenic lines.  
2.  +, bright band was observed by RT-PCR.  
3. √,survival rate study conducted; blank, data not determined.  
4.
 
+, real-time PCR study performed, showing the activation of mMyc downstream 
genes, and the absolute concentration of zvtg1 and mMyc mRNA was calculated; 
blank, data not determined.  
5.
 
+, tumor phenotypes were observed; -, no tumor phenotype was observed. 
 
 
Major conclusions and future directions 
102 
 
6.2 Future directions 
 
In the present study, three types of oncogene transgenic zebrafish were characterized: 
two inducible systems—Tg(lfabp:rtTA;Tre:mMyc-GFP) and Tg(mvtg1:mMyc-GFP), 
and one constitutive expression system—Tg (lfabp:Xmrk). Although each of these 
transgenic lines showed some positive signs of the transgenic expression system or 
even preliminary tumor phenotype, apparently more works are required for further 
characterization of these transgenic lines to establish the zebrafish model for liver 
cancer studies. The following is a summary of some immediate works that should be 
carried out on the basis of the present works. 
 
i. Tg(lfabp:rtTA;Tre:mMyc-GFP) lines  
(1) Long term Dox treatment. Since the tumor development in this transgenic line 
only reached neoplasm stage in the relatively short term study, another batch 
of Dox treatment needs to be carried out for a longer term. The phenotype will 
be observed, and more specific characterization will be carried out such as 
RNA, histology, protein and microarray analysis. In addition, There are two 
stable transgenic lines using this construct, line 32 and line 129. Line 129 will 
also be included in the future work since only line 32 was included in the Dox 
treatment in the present work. 
(2) Recovery analysis. Since inactivation of MYC oncogene is reported to be 
sufficient to induce sustained regression of invasive liver cancers (Catherine et 
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al., 2004), a recovery analysis will also be needed for the tumor-like fish after 
Dox treatment. by removing the Dox and put the fish in clean water. 
(3) Co-operation of oncogene Myc and Ras. Since we have already successfully 
generated K-Ras transgenic zebrafish lines, Tg(lfabp:rtTA;Tre:mMyc-GFP) 
lines will be outcrossed with K-Ras transgenic lines to study the co-operation 
of different oncogenes. 
 
ii. Tg(mvtg1:mMyc-GFP) line:  
(1) Change of oncogene. One advantage of this inducible system is that, the 
transgene expression will be constitutively activated in female adult fish 
without any treatment, while the male adult fish can be used as an internal 
control. However, since the strength of mvtg1 gene promoter may be low in 
zebrafish, it may be good to use for a more potent oncogene (e.g. K-Ras) to 
generate liver cancer model using mvtg1 promoter.  
(2) In addition, for this existing line, we can try to cross with p53 mutant lines to 
see whether the tumor incidence could be increased. 
 
iii. Tg (lfabp:Xmrk) lines:  
(1) This the first study to constitutively express Xmrk in transgenic zebrafish liver, 
as the function of Xmrk in the liver is still unknown. Since these Tg 
(lfabp:Xmrk) lines failed to develop tumors, we can change to use other tissue 
specific promoters or ubiquitous promoters to drive the expression of Xmrk in 




(2) For these existing lines, the double transgenic offspring after crossing Tg 
(lfabp:Xmrk) with p53(-/-) mutant line is still maintained. It would be 
necessary to generate the next generation of this double transgenic line to get 
homozygous transgenic fish, i.e. Xmrk(+/+) &p53(-/-) to further investigate 

































Adam D., Dimitrijevic N., and Schartl M.. Tumor suppression in Xiphophorus by an 
accidentally acquired promoter. Science 259, 816–819 (1993). 
 
Akagi K, Kanai M, Saya H, Kozu T, and Berns A. A novel tetracycline-dependent 
transactivator with E2F4 transcriptional activation domain. Nucleic Acids Research 29 
e23 (2001). 
 
Alix de L. C., Alexandre M., Monique F., Emmanuelle G., Arlette P., Terry V. D., Axel 
K., and Christine P. Paradoxical Inhibition of c-myc-induced Carcinogenesis by Bcl-2 
in Transgenic Mice. Cancer Res 59, 5017–5022, October 1 (1999). 
 
A-Mohammadi S, Alvarez-Vallina L, Ashworth LJ & Hawkins RE Delay in 
resumption of the activity of tetracycline-regulatable promoter following removal of 
tetracycline analogues. Gene Therapy 4 993–997 (1997). 
 
Amsterdam, A. & Hopkins, N. Retrovirus-mediated insertional mutagenesis in 
zebrafish. Methods Cell Biol. 60, 87–98 (1999). 
 
Anders, A., Anders, F., Etiology of cancer as studied in the platyfish– swordtail 
system. Biochim. Biophys. Acta 516, 61–95 (1978). 
 
Baron U and Bujard H, Tet repressor-based system for regulated gene expression in 
eukaryotic cells: Principles and advances. Methods Enzymol 327: 401-21 (2000). 
 
Baudler M, Schartl M, Altschmied J. Specific activation of a STAT family member in 
Xiphophorus melanoma cells. Exp. Cell Res. 249, 212–220 (1999). 
 
Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CD, Morris 
JP, Liu TX, Schulte-Merker S, Kanki JP, Plasterk R, Zon LI, Look AT., tp53 mutant 
zebrafish develop malignant peripheral nerve sheath tumors. PNAS, vol. 102, no. 2, 
407–412 (2005). 
 
Beroud, C. & Soussi, T. The UMD-p53 database: New mutations and analysis tools. 
Hum. Mutat. 21, 176–181 (2003). 
 
Brand, A.H. and Perrimon, N.. Targeted gene expression as a means of altering cell 
fates and generating dominant phenotypes. Development 118: 401-415 (1993). 
 
Bunton, T. E. Experimental chemical carcinogenesis in fish. Toxicol. Pathol. 24, 
603–618 (1996). 
 
Bunton, T. E. Hepatopathology of diethylnitrosamine in the medaka (Oryzias latipes) 





Catherine M. S., Andrew M. K., Constadina A., Asa K., Shelly B., Stefanie M., 
Michael H. B., Alexander D. B., Boris R., Robert D. C., Qiwei Y., J. Michael B., 
Christopher H. C. and Dean W. F. MYC inactivation uncovers pluripotent 
differentiation and tumour dormancy in hepatocellular cancer. Nature, 
28;431(7012):1112-7 (2004). 
 
Dahm, Ralf, "The Zebrafish Exposed", American Scientist 94 (5): 446–453(2006). 
 
Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R. and Bradley, A. A null c-myc 
mutation causes lethality before 10.5 days of gestation in homozygotes and reduced 
fertility in heterozygous female mice. Genes Dev. 7, 671–682 (1993). 
 
Delfgaauw J, Duschl J, Wellbrock C, Froschauer C, Schartl M, Altschmied J. 
MITF-M plays an essential role in transcriptional activation and signal transduction in 
Xiphophorus melanoma. Gene 320, 117–126 (2003). 
 
Detrich, H. W., Westerfield, M. & Zon, L. I. Overview of the Zebrafish system. 
Methods Cell Biol. 59, 3–10 (1999). 
 
Winnemoeller D, Wellbrock C, Schartl M. Activating mutations in the extracellular 
domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo. Int. J. 
Cancer: 117, 723–729 (2005). 
 
Driever, W. & Fishman, M. C. The zebrafish: heritable disorders in transparent 
embryos. J. Clin. Invest. 97, 1788–1794 (1996). 
 
E. Elizabeth Patton, The art and design of genetic screens: zebrafish. Nature Reviews 
Genetics 2, 956-966 (2001). 
 
Efrat S, Fusco-DeMane D, Lemberg H, Emran OL & Wang X Conditional 
transformation of a pancreatic _-cell line derived from transgenic mice expressing a 
tetracycline-regulated oncogene. PNAS 92 3576–3580 (1995). 
 
Eisen, J. S. Zebrafish make a big splash. Cell 87, 969–977 (1996). 
 
Fischer J.A. , Giniger E, Maniatis T and  Ptashne M, GAL4 activates transcription in 
Drosophila, Nature 332, 853 - 856 (1988). 
 
Geissinger E, Weisser C, Fischer P, Schartl M, Wellbrock C. Autocrine stimulation by 
osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. 
Cancer Res. 62, 4820–4828 (2002). 
 
Golling G, Amsterdam A, Sun Z, Antonelli M, Maldonado E, Chen W, Burgess S, 




mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate 
development. Nature Genet. 31, 135–140 (2002). 
 
Gómez A, Wellbrock C, Gutbrod H, Dimitrijevic N, Schartl M. Ligand-independent 
dimerization and activation of the oncogenic Xmrk receptor by two mutations in the 
extracellular domain. J. Biol. Chem. 276, 3333–3340 (2001). 
 
Gong Z, Yan T, Liao J, Lee SE, He J, Hew CL., Rapid identification and isolation of 
zebrafish cDNA clones. Gene, 201, 87–98 (1997). 
 
Gordon, M. Hereditary basis of melanosis in hybrid fishes. Am. J. Cancer 15, 
1495–1523 (1931). 
 
Gordon, M. The genetics of viviparous top-minnow Platypoecilus: the inheritance of 
two kinds of melanophores. Genetics 12, 253– 283 (1927). 
 
Gossen M and Bujard H Anhydrotetracycline, a novel effector of the tetracycline 
controlled gene expression systems in eukaryotic cells. Nucleic Acids Research 21 
4411–4412 (1993). 
Gossen M and Bujard H, Tight control of gene expression in mammalian cells by 
tetracycline-responsive promoters. PNAS 89 5547–5551 (1992). 
 
Gossen M, Freundlieb S, Bender G, Muller G, Hillen W and Bujard H Transcriptional 
activation by tetracyclines in mammalian cells. Science 268 1766–1769 (1995). 
 
Grunwald, D. J. and Streisinger, G. Induction of recessive lethal and specific locus 
mutations in the zebrafish with ethyl nitrosourea. Genet. Res. 59, 103–116 (1992). 
 
Hendricks, J. D. Development of the Zebra Danio model: Carcinogenesis and Gene 
Transfer Studies, US Army, National Information Technology Service, Springfield, 
Virginia (1996). 
 
Her GM, Chiang CC, Chen WY, Wu JL. In vivo studies of liver-type fatty acid 
binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio 
rerio). FEBS Lett 538:125–133. (2003) 
 
Herr W., The herpes simplex virus VP16-induced complex: mechanisms of 
combinatorial transcriptional regulation. Cold Spring Harbor Symposia on 
Quantitative Biology 63 599–607 (1998). 
 
Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer 
progression. Exp Cell Res 284:99–110 (2003). 
 




Reviews Cancer 3, 533-539 (2003). 
 
Huang CJ, Jou TS, Ho YL, Lee WH, Jeng YT, Hsieh FJ and Tsai HJ. Conditional 
expression of a myocardium-specific transgene in zebrafish transgenic lines. 
Developmental dynamics 233:1294-1303 (2005). 
 
Ivan Bubanovic, Origin of anti-tumor immunity failure in mammals (2004). 
 
Feng H, Langenau DM, Madge JA, Quinkertz A, Gutierrez A, Neuberg DS, Kanki JP, 
Look AT, Heat-shock induction of T-cell lymphoma/leukaemia in conditional 
Cre/lox-regulated transgenic zebrafish. British Journal of Haematology, 138, 169–175 
(2007). 
 
Jessen J. R., Jessen T. N., S. S. Vogel, S. Lin, Concurrent expression of recombination 
activating genes 1 and 2 in zebrafish olfactory sensory neurons. Genesis 29, 156 
(2001). 
 
Langenau D. M., Cicely J., Stephane B., Teresa P., John P. K., Jeffery L. K., and A. 
Thomas Look, Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of 
transgenic zebrafish. Blood Vol. 105, No. 8: 3278-3285 (2005b). 
 
Langenau, D. M. et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 
299, 887–890 (2003). 
 
Langenau, D. M., Hui F., Stephane B., John P. Kanki, Jeffery L. K., and A. Thomas 
Look, Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T 
cell acute lymphoblastic leukemia. PNAS April 26, vol. 102, no. 17 (2005a). 
 
Langheinrich, U., Hennen, E., Stott, G. & Vacun, G. Zebrafish as a model organism 
for the identification and characterization of drugs and genes affecting p53 signaling. 
Curr. Biol. 12, 2023–2028 (2002). 
 
Law, J. M. Mechanistic considerations in small fish carcinogenicity testing. Ilar J. 42, 
274–284 (2001). 
 
Long Q, Meng A, Wang H, Jessen JR, Farrell MJ and Lin S.. GATA-1 expression 
pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. 
Development 124, 4105–4111 (1997). 
 
McCallum, C. M., Comai, L., Greene, E. A. & Henikoff, S. Targeting induced local 
lesions in genomes (TILLING) for plant functional genomics. Plant Physiol. 123, 
439–442 (2000). 
 




extracellular domain of the oncogenic EGFR variant Xmrk. Zebrafish 3(3):359-69 
(2006a). 
 
Meierjohann S, Wende E, Kraiss A, Wellbrock C and Schartl M. The oncogenic 
epidermal growth factor receptor variant xiphophorus melanoma receptor kinase 
induces motility in melanocytes by modulation of focal adhesions. Cancer Res. 66, 
3145–3152 (2006b). 
 
Morcinek JC, Weisser C, Geissinger E, Schartl M, and Wellbrock C. Activation of 
STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by 
the oncogenic Xmrk kinase. Oncogene 21, 1668–1678 (2002). 
 
Murakami, H., Sanderson, N. D., Nagy, P., Marino, P. A., Merlino, G., and 
Thorgeirsson, S. S. Transgenic mouse model for synergistic effects of nuclear 
oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming 
growth factor-α  in hepatic oncogenesis. Cancer Res 53, 1719–23 (1993). 
 
Nico Scheer, Jose  ´A. Campos-Ortega. Use of the Gal4-UAS technique for targeted 
gene expression in the zebrafish. Mechanisms of Development 80 153–158 (1999). 
 
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C. and Hainaut, P. The 
IARC TP53 database: new online mutation analysis and recommendations to users. 
Hum. Mutat. 19, 607–614 (2002). 
 
Peterson, R. T., Link, B. A., Dowling, J. E. and Schreiber, S. L. Small molecule 
developmental screens reveal the logic and timing of vertebrate development. Proc. 
Natl Acad. Sci. USA 97, 12965–12969 (2000). 
 
Picker, A., Scholpp, S., Bohli, H., Takeda, H. and Brand, M. A novel positive 
transcriptional feedback loop in midbrain-hindbrain boundary development is 
revealed through analysis of the zebrafish pax2.1 promoter in transgenic lines. 
Development 129, 3227–3239 (2002). 
 
Pirity, M., Blanck, J. K. and Schreiber-Agus, N. Lessons learned from Myc/Max/Mad 
knockout mice. Curr. Top. Microbiol. Immunol. 302, 205–234 (2006). 
 
Rettig, R. A. in Cancer Crusade: The Story of the National Cancer Act of 1971 42–76 
Joseph Henry Press, Washington DC (2000). 
 
Santoni-Rugiu, E., Nagy, P., Jensen, M. R., Factor, V. M., and Thorgeirsson, S. S. 
Evolution of neoplastic development in the liver of transgenic mice co-expressing 
c-myc and transforming growth factor-α . Am J Pathol 149, 407–28. (1996). 
 




loss-of-function mutants in Xiphophorus caused by Xmrk-oncogene deletion and gene 
disruption by a transposable element. Genetics 153, 1385–1394 (1999). 
 
Schartl M.. Evolution of Xmrk: an oncogene,but also a speciation gene? Bioessays. 
Sep, 30(9):822-32 (2008). 
 
Schartl, M., Platyfish and swordtails: a genetic system for the analysis of molecular 
mechanisms in tumor formation. Trends Genet. 11, 185– 189 (1995). 
 
Stanton, M. Diethylnitrosamine-induced hepatic degeneration and neoplasia in the 
aquarium fish, Brachydanio rerio. J. Natl Cancer Inst. 34, 117–130 (1965). 
 
Streisinger, G., Walker, C., Dower, N., Knauber, D. & Singer, F. Production of clones 
of homozygous diploid zebrafish (Brachydanio rerio). Nature 291, 293–296 (1981). 
 
Thorgeirsson, S. S. and Grisham, J. W. Molecular pathogenesis of human 
hepatocellular carcinoma. Nat Genet 31, 339–46. (2002). 
 
Tsai, H. W. Evolution of Zebrafish (Danio rerio) as a Model for Carcinogenesis. Ph.D. 
Thesis, Oregon State Univ., (1996). 
 
Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H & Hillen W  Exploring the 
sequence space for tetracycline-dependent transcriptional activators: novel mutations 
yield expanded range and sensitivity. PNAS 97 7963–7968. (2000a). 
 
Urlinger S, Helbl V, Guthmann J, Pook A, Grimm S & Hillen W The p65 domain of 
NF-kB is an efficient human activator in the tetracycline-regulatable gene expression 
system. Gene 247 103–110. (2000b). 
 
Vogelstein, B. and Kinzler, K.W. The multistep nature of cancer. Trends Genet. 9, 
138–141 (1993). 
 
Volff JN, Körting C, Froschauer A, Zhou Q, Wilde B, Schultheis C, Selz Y, Sweeney 
K, Duschl J, Wichert K, Altschmied J, Schartl M. The Xmrk oncogene can escape 
nonfunctionalization in a highly unstable subtelomeric region of the genome of the 
fish Xiphophorus. Genomics 82, 470–479 (2003). 
 
Walter, R. B. and Kazianis, S. Xiphophorus interspecies hybrids as genetic models of 
induced neoplasia. Ilar J. 42, 299–321 (2001). 
 
Wang H, Tan JT, Emelyanov A, Korzh V, Gong Z. Hepatic and extrahepatic 






Wellbrock, C. and Schartl, M. Activation of phosphatidylinositol 3-kinase by a 
complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant 
transformation of pigment cells. Eur. J. Biochem. 267, 3513–3522 (2000). 
 
Wellbrock, C. and Schartl, M. Multiple binding sites in the growth factor receptor 
Xmrk mediate binding to p59fyn, GRB2 and Shc. Eur. J. Biochem. 260, 275–283 
(1999). 
 
Wellbrock C, Weisser C, Geissinger E, Troppmair J, Schartl M. Activation of p59(Fyn) 
leads to melanocyte dedifferentiation by influencing MKP-1-regulated 
mitogen-activated protein kinase signaling. J. Biol. Chem. 277, 6443–6454 (2002). 
 
Werner, M., Schartl, M., Meierjohann, S., The generation of melanoma model in 
zebrafish. Melanoma Research, September - Volume 16 - Issue - pp S86-S87 (2006). 
Wienholds, E., Schulte-Merker, S., Walderich, B. & Plasterk, R. H. Target-selected 
inactivation of the zebrafish rag1 gene. Science 297, 99–102 (2002). 
 
Wittbrodt J, Adam D, Malitschek B, Mäueler W, Raulf F, Telling A, Robertson SM, 
Schartl M. Nature 341, 415–421 (1989). 
 
Zeng Z, Shan T, Tong Y, Lam SH, Gong Z., Development of estrogen-responsive 
transgenic medaka for environmental monitoring of endocrine disrupters. Environ. Sci. 
Technol., 39, 9001-9008 (2005). 
 
Zunker K, Epplen JT, Schartl M. Genomic stability in malignant melanoma of 
Xiphophorus. Melanoma Res. 16, 105–113 (2006). 
 
 
